SEARCH

SEARCH BY CITATION

References

  • 1
    Pearson RK, Longnecker DS, Chari ST et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 2003; 27: 113.
  • 2
    Kim KP, Kim MH, Lee SS, Seo DW, Lee SK. Autoimmune pancreatitis: it may be a worldwide entity. Gastroenterology 2004; 126: 1214.
  • 3
    Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig. Dis. Sci. 1995; 40: 15618.
  • 4
    Ectors N, Maillet B, Aerts R et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997; 41: 2638.
  • 5
    Kino-Ohsaki J, Nishimori I, Morita M et al. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome. Gastroenterology 1996; 110: 157986.
  • 6
    Okazaki K, Uchida K, Ohana M et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000; 118: 57381.
  • 7
    Chutaputti A, Burrell MI, Boyer JL. Pseudotumor of the pancreas associated with retroperitoneal fibrosis: a dramatic response to corticosteroid therapy. Am. J. Gastroenterol. 1995; 90: 11558.
  • 8
    Klimstra DS, Conlon KC, Adsay NV. Lymphoplasmacytic sclerosing pancreatitis with pseudotumor formation. Pathol. Case Rev. 2001; 6: 949.
  • 9
    Romboli E, Campana D, Piscitelli L et al. Pancreatic involvement in systemic sarcoidosis. A case report. Dig. Liver Dis. 2004; 36: 2227.
  • 10
    Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am. J. Surg. Pathol. 2003; 27: 111927.
  • 11
    Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum. Pathol. 1991; 22: 38795.
  • 12
    Pezzilli R, Casadei R, Calculli L, Santini D. Autoimmune pancreatitis. A case mimicking carcinoma. JOP 2004; 5: 52730.
  • 13
    Okazaki K. Clinical relevance of autoimmune-related pancreatitis. Best Pract. Res. Clin. Gastroenterol. 2002; 16: 36578.
  • 14
    Ghazale A, Chari ST, Smyrk TC et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am. J. Gastroenterol. 2007; 102: 164653.
    Direct Link:
  • 15
    Choi EK, Kim MH, Lee TY et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis—Korean experience. Pancreas 2007; 35: 15863.
  • 16
    Hirano K, Kawabe T, Yamamoto N et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin. Chim. Acta 2006; 367: 1814.
  • 17
    Aparisi L, Farre A, Gomez-Cambronero L et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 2005; 54: 7039.
  • 18
    Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity autoimmune pancreatitis-associated sclerosing cholangitis. Pathol. Int. 2005; 55: 40511.
  • 19
    Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006; 6: 1327.
  • 20
    Hamano H, Kawa S, Horiuchi A et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 2001; 344: 7328.
  • 21
    Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand. J. Gastroenterol. 2004; 39: 11548.
  • 22
    Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern. Med. 2006; 45: 497501.
  • 23
    Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46: 46371.
  • 24
    Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med. Res. Methodol. 2006; 6: 31.
  • 25
    Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat. Med. 2002; 21: 123756.
  • 26
    Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat. Med. 1993; 12: 1293316.
  • 27
    Irwig L, Macaskill P, Glasziou P, Fahey M. Meta-analytic methods for diagnostic test accuracy. J. Clin. Epidemiol. 1995; 48: 11930.
  • 28
    Walter SD. Small sample estimation of log odds ratios from logistic regression and fourfold tables. Stat. Med. 1985; 4: 43744.
  • 29
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 17788.
  • 30
    Macaskill P. Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis. J. Clin. Epidemiol. 2004; 57: 92532.
  • 31
    Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat. Med. 2002; 21: 152537.
  • 32
    Fantini L, Zanini N, Fiscaletti M et al. Autoimmune pancreatitis: the classification puzzle. Adv. Med. Sci. 2007; 52: 715.
  • 33
    Okazaki K, Kawa S, Kamisawa T et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J. Gastroenterol. 2006; 41: 62631.
  • 34
    Cavallini G, Frulloni L. Autoimmunity and chronic pancreatitis: a concealed relationship. JOP 2001; 2: 618.
  • 35
    Pezzilli R. New insights into the pathology and treatment of autoimmune pancreatitis. JOP 2005; 6: 1979.
  • 36
    Aalberse RC, Van Milligen F, Tan KY, Stapel SO. Allergen-specific IgG4 in atopic disease. Allergy 1993; 48: 55969.
  • 37
    Hussain R, Poindexter RW, Ottesen EA. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J. Immunol. 1992; 148: 27317.
  • 38
    Shirakata Y, Shiraishi S, Sayama K, Miki Y. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J. Dermatol. 1990; 17: 6616.
  • 39
    Malik SA, Van Kley H, Knight WA Jr. Inherited defect in hereditary pancreatitis. Am. J. Dig. Dis. 1977; 22: 9991004.
  • 40
    Foy A, Smart C, Duggan JM, Major GA, Clancy R. Immune complexes in acute pancreatitis. Aust. N. Z. J. Med. 1981; 11: 6059.
  • 41
    Skaarup P, Jørgensen T, Larsen S. Asynchronous metastasizing renal cell carcinoma associated with progressive immune complex glomerulonephritis and proteinuria. Scand. J. Urol. Nephrol. 1984; 18: 3516.
  • 42
    Rhodes EG, Boesen EA, Corringham RE, Matthews KB, Tuddenham EG, Kernoff PB. Disappearance of antibodies to factor VIII in a patient with acquired haemophilia and carcinoma of the pancreas during cytotoxic therapy with fluorouracil and CCNU. Thromb. Haemost. 1984; 52: 1313.
  • 43
    Reynolds HY. Respiratory infections may reflect deficiencies in host defense mechanisms. Dis. Mon. 1985; 31: 198.
  • 44
    Laufer P. Assessment of corticosteroid therapy for allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis. J. Asthma 1985; 22: 2535.
  • 45
    Slavin RG, Bedrossian CW, Hutcheson PS et al. A pathologic study of allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 1988; 81: 71825.
  • 46
    Bäckman L, Brattström C, Reinholt FP, Andersson J, Tydén G. Development of intrapancreatic abscess—a consequence of CMV pancreatitis? Transpl. Int. 1991; 4: 11621.
  • 47
    Ciofu C, Laky D, Geormaneanu M. Kawasaki disease in an infant with cystic fibrosis. Rom. J. Morphol. Embryol. 1992; 38: 636.
  • 48
    Scheinin S, Radovancevic B, Frazier OH. Acute pancreatitis complicating OKT3 administration for resistant cardiac rejection. Transpl. Proc. 1993; 25: 23689.
  • 49
    Shrier LA, Karpen SJ, McEvoy C. Acute pancreatitis associated with acute hepatitis A in a young child. J. Pediatr. 1995; 126: 579.
  • 50
    Root MV, Johnson KH, Allen WT, Johnston SD. Diabetes mellitus associated with pancreatic endocrine insufficiency in a kitten. J. Small Anim. Pract. 1995; 36: 41620.
  • 51
    Hemmelder MH, De Zeeuw D, De Jong PE. Measurement of glomerular charge selectivity in non-diabetic renal disease. Nephrol. Dial. Transplant. 1997; 12 (Suppl. 2): 5762.
  • 52
    Weber P, Zimmer KP, Husemann S, Harms E. False-positive gliadin and endomysium antibodies and exocrine pancreatic insufficiency as pitfalls in the differential diagnosis of duodenal Crohn's versus celiac disease. Am. J. Gastroenterol. 1998; 93: 11779.
    Direct Link:
  • 53
    Perniciaro C, Rappaport KD, White JW Jr. Apoptosis with positive direct immunofluorescence findings in a patient with necrolytic migratory erythema. Cutis 1998; 62: 12932.
  • 54
    Okumura Y, Tamba J, Shintani Y et al. Macrolipasemia in Crohn's disease. Pancreas 1998; 16: 20510.
  • 55
    Gaburri PD, Chebli JM, Quinet de Andrade Perez LV, Quinet de Andrade L. Autoimmune pancreatitis and hepatitis: an uncommon association. Am. J. Gastroenterol. 2000; 95: 23914.
    Direct Link:
  • 56
    Keating JP, Lowe ME. Persistent hyperlipasemia caused by macrolipase in an adolescent. J. Pediatr. 2002; 141: 12931.
  • 57
    Hamano H, Kawa S, Ochi Y et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359: 14034.
  • 58
    Chen RY, Adams DB. IgG4 levels in non-Japanese patients with autoimmune sclerosing pancreatitis. N. Engl. J. Med. 2002; 346: 1919.
  • 59
    Nakamura A, Funatomi H, Katagiri A et al. A case of autoimmune pancreatitis complicated with immune thrombocytopenia during maintenance therapy with prednisolone. Dig. Dis. Sci. 2003; 48: 196871.
  • 60
    Hirano K, Komatsu Y, Yamamoto N et al. Pancreatic mass lesions associated with raised concentration of IgG4. Am. J. Gastroenterol. 2004; 99: 203840.
    Direct Link:
  • 61
    Uchiyama-Tanaka Y, Mori Y, Kimura T et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am. J. Kidney Dis. 2004; 43: e1825.
  • 62
    Banner NR, Rose ML, Cummins D et al. Management of an ABO-incompatible lung transplant. Am. J. Transplant. 2004; 4: 11926.
  • 63
    Pickartz T, Pickartz H, Lochs H, Ockenga J. Overlap syndrome of autoimmune pancreatitis and cholangitis associated with secondary Sjögren's syndrome. Eur. J. Gastroenterol. Hepatol. 2004; 16: 12959.
  • 64
    Taniguchi T, Ko M, Seko S et al. Interstitial pneumonia associated with autoimmune pancreatitis. Gut 2004; 53: 770.
  • 65
    Nishimura T, Masaoka T, Suzuki H, Aiura K, Nagata H, Ishii H. Autoimmune pancreatitis with pseudocysts. J. Gastroenterol. 2004; 39: 100510.
  • 66
    Takeda S, Haratake J, Kasai T, Takaeda C, Takazakura E. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol. Dial. Transplant. 2004; 19: 4746.
  • 67
    Sahin P, Pozsár J, Simon K, Illyés G, László F, Topa L. Autoimmune pancreatitis associated with immune-mediated inflammation of the papilla of Vater: report on two cases. Pancreas 2004; 29: 1626.
  • 68
    Zen Y, Kasahara Y, Horita K et al. Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: histologic similarity to sclerosing pancreatitis. Am. J. Surg. Pathol. 2005; 29: 2758.
  • 69
    Knutsen AP, Noyes B, Warrier MR, Consolino J. Allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis: diagnostic criteria when the IgE level is less than 500 IU/mL. Ann. Allergy Asthma Immunol. 2005; 95: 48893.
  • 70
    Plaza JA, Colonna J, Vitellas KM, Frankel WL. Lymphoplasmacytic sclerosing pancreatitis. Ann. Diagn. Pathol. 2005; 9: 298301.
  • 71
    Ford AC, Chalmers AG, Hamlin PJ. Image of the month. Autoimmune pancreatitis. Gastroenterology 2005; 129: 785, 1141.
  • 72
    Hamano H, Kawa S, Uehara T et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest. Endosc. 2005; 62: 1527.
  • 73
    Fukumori K, Shakado S, Miyahara T et al. Atypical manifestations of pancreatitis with autoimmune phenomenon in an adolescent female. Intern. Med. 2005; 44: 88691.
  • 74
    Muraki T, Hamano H, Ochi Y et al. Corticosteroid-responsive pancreatic cyst found in autoimmune pancreatitis. J. Gastroenterol. 2005; 40: 7616.
  • 75
    Yamamoto M, Ohara M, Suzuki C et al. A case of Mikulicz's disease complicated by autoimmune pancreatitis, in which impaired glucose tolerance was improved by glucocorticoid treatment. Jpn J. Clin. Immunol. 2005; 28: 34956.
  • 76
    Kamisawa T, Matsukawa M, Ohkawa M. Autoimmune pancreatitis associated with retroperitoneal fibrosis. JOP 2005; 6: 2603.
  • 77
    Sewkani A, Kapoor S, Sharma S, Naik S, Debbarma MK, Varshney S. IgG4 negative sclerosing cholangitis associated with autoimmune pancreatitis. JOP 2005; 6: 26973.
  • 78
    Gumbs AA, Kim J, Kiehna E, Brink JA, Salem RR. Autoimmune pancreatitis presenting as simultaneous masses in the pancreatic head and gallbladder. JOP 2005; 6: 4559.
  • 79
    Hackert T, Hartwig W, Friess H, Buchler MW, Werner J. Acute retinopathy following pancreatic head resection for chronic pancreatitis: a rare, severe complication. JOP 2005; 6: 4603.
  • 80
    Kanno A, Satoh K, Kimura K et al. Autoimmune pancreatitis with hepatic inflammatory pseudotumor. Pancreas 2005; 31: 4203.
  • 81
    Fukui T, Okazaki K, Yoshizawa H et al. A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjögren's syndrome. Pancreatology 2005; 5: 8691.
  • 82
    Ichikawa T, Nakao K, Hamasaki K, Ohkubo K, Toriyama K, Eguchi K. An autopsy case of acute pancreatitis with a high serum IgG4 complicated by amyloidosis and rheumatoid arthritis. World J. Gastroenterol. 2005; 11: 20324.
  • 83
    Sasahira N, Kawabe T, Nakamura A et al. Inflammatory pseudotumor of the liver and peripheral eosinophilia in autoimmune pancreatitis. World J. Gastroenterol. 2005; 11: 9225.
  • 84
    Taguchi M, Aridome G, Abe S et al. Autoimmune pancreatitis with IgG4-positive plasma cell infiltration in salivary glands and biliary tract. World J. Gastroenterol. 2005; 11: 557781.
  • 85
    Honda T, Ito M, Niino D et al. Autoimmune pancreatitis with primary sclerosing cholangitis-like lesion. Acta Med. Nagasaki. 2006; 51: 358.
  • 86
    Watson SJ, Jenkins DA, Bellamy CO. Nephropathy in IgG4-related systemic disease. Am. J. Surg. Pathol. 2006; 30: 14727.
  • 87
    Lee WC, Wu MJ, Cheng CH et al. Acute pancreatitis following antilymphocyte globulin therapy in a renal transplant recipient. Clin. Nephrol. 2006; 65: 1446.
  • 88
    Rudmik L, Trpkov K, Nash C et al. Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours. CMAJ 2006; 175: 3679.
  • 89
    De Las Heras-Castan~o G, Castro-Senosiain B, García-Suárez C et al. Autoimmune pancreatitis. An infrequent or underdiagnosed entity? Pathological, clinical and immunological characteristics. Gastroenterol. Hepatol. 2006; 29: 299305.
  • 90
    Zen Y, Sawazaki A, Miyayama S, Notsumata K, Tanaka N, Nakanuma Y. A case of retroperitoneal and mediastinal fibrosis exhibiting elevated levels of IgG4 in the absence of sclerosing pancreatitis (autoimmune pancreatitis). Hum. Pathol. 2006; 37: 23943.
  • 91
    Esposito S, Colombo C, Ravaglia R et al. Mycoplasma Pneumoniae pericarditis and cardiac tamponade in a 7-year-old girl with cystic fibrosis. Infection 2006; 34: 3556.
  • 92
    Miyajima N, Koike H, Kawaguchi M, Zen Y, Takahashi K, Hara N. Idiopathic retroperitoneal fibrosis associated with IgG4-positive-plasmacyte infiltrations and idiopathic chronic pancreatitis. Int. J. Urol. 2006; 13: 14424.
  • 93
    Yoshimura Y, Takeda S, Ieki Y, Takazakura E, Koizumi H, Takagawa K. IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern. Med. 2006; 45: 897901.
  • 94
    Saeki T, Saito A, Hiura T et al. Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease. Intern. Med. 2006; 45: 1637.
  • 95
    Kamisawa T, Nakajima H, Hishima T. Close correlation between chronic sclerosing sialadenitis and immunoglobulin G4. Intern. Med. J. 2006; 36: 5279.
  • 96
    Schmoldt S, Latzin P, Heesemann J, Griese M, Imhof A, Hogardt M. Clonal analysis of Inquilinus limosus isolates from six cystic fibrosis patients and specific serum antibody response. J. Med. Microbiol. 2006; 55: 142533.
  • 97
    Bartholomew SV, Zigman A, Sheppard B. Lymphoplasmacytic sclerosing pancreatitis presenting as a pancreatic head mass in a child: case report and management recommendations. J. Pediatr. Surg. 2006; 41: e235.
  • 98
    Shimoda M, Kubota K, Sawada T et al. Autoimmune pancreatitis diagnosed on the basis of immunohistology alone. A case report. JOP 2006; 7: 47881.
  • 99
    Kawabe K, Ito T, Arita Y, Nakamuta M, Nawata H, Takayanagi R. Successful treatment of advanced-stage autoimmune pancreatitis-related sclerosing cholangitis. Pancreas 2006; 33: 4347.
  • 100
    Nakamura H, Wada H, Origuchi T et al. A case of IgG4-related autoimmune disease with multiple organ involvement. Scand. J. Rheumatol. 2006; 35: 6971.
  • 101
    Sulz MC, Geyer M, Peter S, Degen L. Serum immunoglobin G4 (IgG4): an important marker in autoimmune pancreatitis? Swiss Med. Wkly. 2006; 136: 5447.
  • 102
    Mizukami H, Yajima N, Wada R et al. Pancreatic malignant fibrous histiocytoma, inflammatory myofibroblastic tumor, and inflammatory pseudotumor related to autoimmune pancreatitis: characterization and differential diagnosis. Virchows Arch. 2006; 448: 55260.
  • 103
    Kamisawa T, Chen PY, Tu Y, Nakajima H, Egawa N. Autoimmune pancreatitis metachronously associated with retroperitoneal fibrosis with IgG4-positive plasma cell infiltration. World J. Gastroenterol. 2006; 12: 29557.
  • 104
    Kamisawa T, Chen PY, Tu Y et al. Pancreatic cancer with a high serum IgG4 concentration. World J. Gastroenterol. 2006; 12: 62258.
  • 105
    Welsch T, Kleeff J, Esposito I, Büchler MW, Friess H. Autoimmune pancreatitis associated with a large pancreatic pseudocyst. World J. Gastroenterol. 2006; 12: 59046.
  • 106
    Murashima M, Tomaszewski J, Glickman JD. Chronic tubulointerstitial nephritis presenting as multiple renal nodules and pancreatic insufficiency. Am. J. Kidney Dis. 2007; 49: e710.
  • 107
    Yoneda K, Murata K, Katayama K et al. Tubulointerstitial nephritis associated with IgG4-related autoimmune disease. Am. J. Kidney Dis. 2007; 50: 45562.
  • 108
    Kawamura E, Habu D, Higashiyama S et al. A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET. Ann. Nucl. Med. 2007; 21: 2238.
  • 109
    Falck VG, Dixon E. Pseudocysts may be seen in immunoglobulin G4-associated autoimmune pancreatitis. Arch. Pathol. Lab. Med. 2007; 131: 16.
  • 110
    Saeki T, Saito A, Yamazaki H et al. Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin. Exp. Nephrol. 2007; 11: 16873.
  • 111
    Matsuda M, Hamano H, Yoshida T et al. Sjögren syndrome with asymptomatic autoimmune sclerosing pancreatitis. Clin. Rheumatol. 2007; 26: 11719.
  • 112
    Mishima S, Mizuta Y, Yamao T et al. Autoimmune pancreatitis with extreme elevation of DUPAN-2. Intern. Med. 2007; 46: 37781.
  • 113
    Miwa I, Watanabe F, Maruyama Y et al. A case of Castleman's disease (plasma cell type) in which autoimmune pancreatitis developed 6 years later. Jpn J. Gastroenterol. 2007; 104: 23944.
  • 114
    Ohtsubo K, Watanabe H, Tsuchiyama T et al. A case of autoimmune pancreatitis associated with retroperitoneal fibrosis. JOP 2007; 8: 3205.
  • 115
    Toomey DP, Swan N, Torreggiani W, Conlon KC. Autoimmune pancreatitis: medical and surgical management. JOP 2007; 8: 33543.
  • 116
    Kobayashi S, Yoshida M, Kitahara T, Abe Y, Tsuchida A, Nojima Y. Autoimmune pancreatitis as the initial presentation of systemic lupus erythematosus. Lupus 2007; 16: 1336.
  • 117
    Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod. Pathol. 2007; 20: 238.
  • 118
    Ralli S, Lin J, Farrell J. Autoimmune pancreatitis. N. Engl. J. Med. 2007; 356: 1586.
  • 119
    Nishi H, Tojo A, Onozato ML et al. Anti-carbonic anhydrase II antibody in autoimmune pancreatitis and tubulointerstitial nephritis. Nephrol. Dial. Transplant. 2007; 22: 12735.
  • 120
    Hamed G, Tsushima K, Yasuo M et al. Inflammatory lesions of the lung, submandibular gland, bile duct and prostate in a patient with IgG4-associated multifocal systemic fibrosclerosis. Respirology 2007; 12: 4557.
  • 121
    Wada K, Shinoda T, Yoshimoto H. A case report of autoimmune pancreatitis accompanied with rapidly developing hyperglycemia and hypertension in a chronic hemodialysis patient. Ther. Apher. Dial. 2007; 11: 1504.
  • 122
    Ammann AJ, Hong R. Selective IgA deficiency and autoimmunity. Clin. Exp. Immunol. 1970; 7: 8338.
  • 123
    Svartz N. Serum macroglobulins in different diseases. Pol. Arch. Med. Wewn. 1970; 4: 31730.
  • 124
    Ginsberg AL. Alterations in immunologic mechanisms in diseases of the gastrointestinal tract. Am. J. Dig. Dis. 1971; 16: 6180.
  • 125
    Barnett B, Meilman E, Han CD. Measurement of the rehological properties of biological fluids II. Biorheology 1971; 8: 717.
  • 126
    Svartz N. Macroglobulins in rheumatoid arthritis and allied diseases. Semin. Arthritis Rheum. 1971; 1: 14160.
  • 127
    Yohe RM. Allergy in patients with cystic fibrosis. Ann. Allergy 1972; 30: 62731.
  • 128
    Abramson N, Shattil SJ. M-components. JAMA 1973; 223: 1569.
  • 129
    Conover JH, Beratis NG, Conod EJ, Ainbender E, Hirschhorn K. Studies on ciliary dyskinesia factor in cystic fibrosis. II. Short term leukocyte cultures and long term lymphoid lines. Pediatr. Res. 1973; 7: 2248.
  • 130
    Beratis NG, Conover JH, Conod EJ, Bonforte RJ, Hirschhorn K. Studies on ciliary dyskinesia factor in cystic fibrosis. 3. Skin fibroblasts and cultured amniotic fluid cells. Pediatr. Res. 1973; 7: 95864.
  • 131
    Ryley HC, Neale L, Brogan TD, Bray PT. Plasma proteins in meconium from normal infants and from babies with cystic fibrosis. Arch. Dis. Child 1974; 49: 9014.
  • 132
    Wallwork JC, Brenchley P, McCarthy J et al. Some aspects of immunity in patients with cystic fibrosis. Clin. Exp. Immunol. 1974; 18: 30320.
  • 133
    Young LS. Role of antibody in infections due to Pseudomonas aeruginosa. J. Infect. Dis. 1974; 130 (Suppl.): S11118.
  • 134
    Polley MJ, Bearn AG. Cystic fibrosis: current concepts. J. Med. Genet. 1974; 11: 24952.
  • 135
    Cohen FL, Daniel WL. Effects of cystic fibrosis sera on Proteus vulgaris motility. J. Med. Genet. 1974; 11: 2536.
  • 136
    Conover JH, Conod EJ, Hirschhorn K. Studies on ciliary dyskinesia factor in cystic fibrosis IV. Its possible identification as anaphylatoxin (C3a)–IgG complex. Life Sci. 1974; 14: 25366.
  • 137
    Bowman BH, Lankford BJ, Fuller GM, Carson SD, Kurosky A, Barnett DR. Cystic fibrosis: the ciliary inhibitor is a small polypeptide associated with immunoglobulin G. Biochem. Biophys. Res. Commun. 1975; 64: 131015.
  • 138
    McFarlane H, Holzel A, Brenchley P et al. Immune complexes in cystic fibrosis. Br. Med. J. 1975; 1: 4238.
  • 139
    Changus JE, Pitot HC. Cystic fibrosis. A dilemma in the metabolic pathogenesis of genetic disease. Arch. Pathol. Lab. Med. 1976; 100: 711.
  • 140
    Di Sant'Agnese PA, Davis PB. Research in cystic fibrosis (second of three parts). N. Engl. J. Med. 1976; 295: 53441.
  • 141
    Soto JM, Aufses AH Jr, Dreiling DA. The pancreas and immunoglobulins III. Secretory levels of immunoglobulins G, A, M in patients with hypersecretory disease, postkidney transplantation and pancreatic carcinoma. A new diagnostic test. Am. J. Gastroenterol. 1977; 68: 347.
  • 142
    Conover JH, Conod EJ. The influence of cystic fibrosis serum and calcium on secretion in the rabbit tracheal mucociliary apparatus. Biochem. Biophys. Res. Commun. 1978; 83: 1595601.
  • 143
    Romeo G, Parsons M, Bossen A, Blessing-Moore J, Cavalli-Sforza L. Trypsin-binding IgG in cystic fibrosis. Nature 1978; 274: 90911.
  • 144
    Bogart BI, Conod EJ, Gaerlan PF, Denning CR, Conover J. Biological activities of cystic fibrosis serum. III. CF serum induced uptake of 45Ca++ by rabbit tracheal explants. Biochem. Biophys. Res. Commun. 1979; 88: 1398404.
  • 145
    Hein J, David A, Grimm J, Gottschalk B. Protein, IgA, secretory IgA, IgG and electrolytes as parameters of parotid gland function in children with cystic fibrosis. Monogr. Paediatr. 1979; 10: 1357.
  • 146
    Carswell F, Oliver J, Silverman M. The cystic fibrosis gene, IgE and IgG4. Monogr. Paediatr. 1979; 10: 1447.
  • 147
    Nielsen H. Circulating immune complexes: properties, methods for detection and disease models. Acta Pathol. Microbiol. Scand. Suppl. 1980; 273 (Suppl.): 155.
  • 148
    Wang A, Turner MW, Soothill JF, Warner JO, Norman AP. Proteus vulgaris agglutination by cystic fibrosis sera. Arch. Dis. Child 1980; 55: 1303.
  • 149
    Burdon MG, Stuart AB. The agglutination of Proteus vulgaris by cystic fibrosis serum: a re-examination. Clin. Genet. 1980; 17: 24954.
  • 150
    Chu TM, Maidment BW Jr, Koestler TP et al. Immune complexes and cancer. Lab. Res. Methods Biol. Med. 1983; 8: 25968.
  • 151
    Yanagihara Y, Shida T. Immunological studies on patients who received aprotinin therapy. Arerugi 1985; 34: 899904.
  • 152
    Moss RB. IgG subclasses in respiratory disorders: cystic fibrosis. Monogr. Allergy 1986; 19: 2029.
  • 153
    Reynolds HY. Identification and role of immunoglobulins in respiratory secretions. Eur. J. Respir. Dis. Suppl. 1987; 153: 10316.
  • 154
    Emmett M, Miller JL, Crowle AJ. Protein abnormalities in adult respiratory distress syndrome, tuberculosis, and cystic fibrosis sera. Proc. Soc. Exp. Biol. Med. 1987; 184: 7482.
  • 155
    Van den Abbeele AD, Aaronson RA, Adelstein SJ, Kassis AI. Does the in vitro testing of the immunoreactivity of an antibody reflect its in vivo behavior? J. Nucl. Med. Allied Sci. 1988; 32: 2607.
  • 156
    Chatfield S, Owen G, Ryley H, Goodchild M, Weller P. Does early detection lead to an improved prognosis in cystic fibrosis neonates? Acta Univ. Carol. [Med.] (Praha) 1990; 36: 968.
  • 157
    Brett MM, Ghoneim AT, Littlewood JM. Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis. Arch. Dis. Child 1990; 65: 25963.
  • 158
    Olds LC, Miller JJ III. C3 activation products correlate with antibodies to lipid A in pauciarticular juvenile arthritis. Arthritis Rheum 1990; 33: 5204.
  • 159
    Cipolli M, Valletta EA, Zampieri C, Mastella G. Increased serum levels of antigliadin antibodies in cystic fibrosis. Acta Paediatr. 1993; 82: 957.
  • 160
    Arruda LK, Muir A, Vailes LD, Selden RF, Platts-Mills TA, Chapman MD. Antibody responses to Aspergillus fumigatus allergens in patients with cystic fibrosis. Int. Arch. Allergy Immunol. 1995; 107: 41011.
  • 161
    Pressler T. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. APMIS. Suppl. 1996; 66: 141.
  • 162
    Rubin BK. Emerging therapies for cystic fibrosis lung disease. Chest 1999; 115: 11206.
  • 163
    Godding V, Vaerman JP, Sibille Y. Secretory mucosal immune mechanisms. Acta Otorhinolaryngol. Belg. 2000; 54: 25561.
  • 164
    Khalid A, Whitcomb DC. The importance of autoimmune pancreatitis. Gastroenterology 2001; 121: 151820.
  • 165
    Hammel P. Autoimmune chronic pancreatitis. Med. Hyg. 2002; 60: 161518.
  • 166
    DiMagno EP. Autoimmune chronic pancreatitis: a plea for simplification and consistency. Clin. Gastroenterol. Hepatol. 2003; 1: 4212.
  • 167
    Pezzilli R, Corinaldesi R. IgG4 as a serological marker of autoimmune pancreatitis: the latest news. JOP 2004; 5: 5313.
  • 168
    Klimstra DS, Adsay NV. Lymphoplasmacytic sclerosing (autoimmune) pancreatitis. Semin. Diagn. Pathol. 2004; 21: 23746.
  • 169
    Deshpande V, Mino-Kenudson M, Brugge W, Lauwers GY. Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Arch. Pathol. Lab. Med. 2005; 129: 114854.
  • 170
    Chetty R, Vajpeyi R. Lymphoplasmacytic sclerosing pancreatitis. Curr. Diagn. Pathol. 2005; 11: 95101.
  • 171
    Ketikoglou I, Moulakakis A. Autoimmune pancreatitis. Dig. Liver Dis. 2005; 37: 21115.
  • 172
    Okazaki K, Uchida K, Matsushita M, Takaoka M. Autoimmune pancreatitis. Intern. Med. 2005; 44: 121523.
  • 173
    Yeo CJ. Autoimmune sclerosing pancreatitis: the surgeon's perspective. J. Gastrointest. Surg. 2005; 9: 1114.
  • 174
    Mino-Kenudson M, Lauwers GY. Histopathology of autoimmune pancreatitis: recognized features and unsolved issues. J. Gastrointest. Surg. 2005; 9: 610.
  • 175
    Morana G, Tapparelli M, Faccioli N, D'Onofrio M, Pozzi Mucelli R. Autoimmune pancreatitis: instrumental diagnosis. JOP 2005; 6 (Suppl. 1): 1027.
  • 176
    Okazaki K. Autoimmune pancreatitis: etiology, pathogenesis, clinical findings and treatment. The Japanese experience. JOP 2005; 6 (Suppl. 1): 8996.
  • 177
    Andren-Sandberg A, Hardt PD. Giessen international workshop on interactions of exocrine and endocrine pancreatic diseases. Castle of Rauischholzhausen of the Justus-Liebig-University, Giessen, Germany. March 18–19, 2005. JOP 2005; 6: 382405.
  • 178
    Adsay NV, Basturk O, Thirabanjasak D. Diagnostic features and differential diagnosis of autoimmune pancreatitis. Semin. Diagn. Pathol. 2005; 22: 30917.
  • 179
    Ahmed SA, Wray C, Rilo HL et al. Chronic pancreatitis: recent advances and ongoing challenges. Curr. Probl. Surg. 2006; 43: 127238.
  • 180
    Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J. Gastroenterol. 2006; 41: 61325.
  • 181
    László C. Autoimmune pancreatitis—An underdiagnosed disease? Lege Artis Med. 2006; 16: 50510.
  • 182
    Seicean A, Grigorescu M, Seicean R. Autoimmune chronic pancreatitis. Rom. J. Intern. Med. 2006; 44: 1724.
  • 183
    Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J. Gastroenterol. 2006; 12: 248796.
  • 184
    Fernandez EMLT, Luis HD, Malagon AM, Gonzalez IA, Pallares AC. Recurrence of inflammatory pseudotumor in the distal bile duct: lessons learned from a single case and reported cases. World J. Gastroenterol. 2006; 12: 393843.
  • 185
    Kellera J, Andresena V, Rosiena U, Layer P. The patient with slightly elevated pancreatic enzymes and abdominal complaints. Best Pract. Res. Clin. Gastroenterol. 2007; 21: 51933.
  • 186
    Maggs JRL, Chapman RW. Sclerosing cholangitis. Curr. Opin. Gastroenterol. 2007; 23: 31016.
  • 187
    Krasinskas AM, Raina A, Khalid A, Tublin M, Yadav D. Autoimmune pancreatitis. Gastroenterol. Clin. North Am. 2007; 36: 23957, vii.
  • 188
    Witt H, Apte MV, Keim V, Wilson JS. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 2007; 132: 155773.
  • 189
    Forsmark CE, Baillie J, AGA Institute Clinical Practice and Economics Committee, AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology 2007; 132: 202244.
  • 190
    Silverman WB. Autoimmune pancreatitis: more common and important than we thought? Gastrointest. Endosc. 2007; 65: 10910.
  • 191
    Löhr JM. What are the useful biological and functional markers of early-stage chronic pancreatitis? J. Gastroenterol. 2007; 42 (Suppl. 17): 6671.
  • 192
    Ohara H, Nakazawa T, Ando T, Joh T. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J. Gastroenterol. 2007; 42 (Suppl. 18): 1521.
  • 193
    Klöppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T. Autoimmune pancreatitis: histo- and immunopathological features. J. Gastroenterol. 2007; 42 (Suppl. 18): 2831.
  • 194
    Okazaki K, Uchida K, Matsushita M, Takaoka M. How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J. Gastroenterol. 2007; 42 (Suppl. 18): 328.
  • 195
    Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J. Gastroenterol. 2007; 42 (Suppl. 18): 3941.
  • 196
    Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J. Gastroenterol. 2007; 42 (Suppl. 18): 914.
  • 197
    Kim MH, Kwon S. Diagnostic criteria for autoimmune chronic pancreatitis. J. Gastroenterol. 2007; 42 (Suppl. 18): 429.
  • 198
    Kamisawa T, Okamoto A. Prognosis of autoimmune pancreatitis. J. Gastroenterol. 2007; 42 (Suppl. 18): 5962.
  • 199
    Pickartz T, Mayerle J, Lerch MM. Autoimmune pancreatitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2007; 4: 31423.
  • 200
    Kwon S, Kim MH, Choi EK. The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus. Pancreas 2007; 34: 27986.
  • 201
    Conover JH, Conod EJ, Hirschhorn K. Letter: complement components in cystic fibrosis. Lancet 1973; 2: 1501.
  • 202
    Conover JH, Conod EJ. Letter: complement in cystic fibrosis. Lancet 1975; 1: 478.
  • 203
    Fick RB Jr. Hypogammaglobulinemia in cystic fibrosis. N. Engl. J. Med. 1980; 302: 1366.
  • 204
    Whyte J. Hypogammaglobulinemia in cystic fibrosis. N. Engl. J. Med. 1980; 302: 1366.
  • 205
    Vazquez C, Aramburu N, Sojo A, Vitoria JC, Pascual C. IgG antibodies to Aspergillus fumigatus in cystic fibrosis. Arch. Dis. Child 1989; 64: 10945.
  • 206
    Nikolaizik WH, Schöni MH. Serum IgG titres against Pseudomonas aeruginosa. Arch. Dis. Child 1993; 68: 432.
  • 207
    Aithal GP, Breslin NP, Gumustop B. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 2001; 345: 1478.
  • 208
    Horiuchi A, Kawa S, Hamano H, Hayashi Y, Kiyosawa K. Does a lack of reactivity to alfa-fodrin indicate the existence of primary autoimmune pancreatitis? Am. J. Gastroenterol. 2002; 97: 12757.
  • 209
    Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am. J. Gastroenterol. 2003; 98: 281112.
    Direct Link:
  • 210
    Varadarajulu S, Cotton PB. Autoimmune pancreatitis: is it relevant in the west? Gastroenterology 2003; 125: 1557.
  • 211
    Okazaki K. Autoimmune pancreatitis is increasing in Japan. Gastroenterology 2003; 125: 15578.
  • 212
    Kamisawa T, Funata N, Hayashi Y. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am. J. Surg. Pathol. 2004; 28: 1114.
  • 213
    Smyth RL. Intravenous immunoglobulin for cystic fibrosis lung disease. Arch. Dis. Child 2004; 89: 2989.
  • 214
    Hughes DB, Grobmyer SR, Brennan MF. Preventing pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis: cost effectiveness of IgG4. Pancreas 2004; 29: 167.
  • 215
    Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis. Pancreas 2004; 29: 1678.
  • 216
    Kamisawa T. Angiographic findings in patients with autoimmune pancreatitis. Radiology 2005; 236: 371.
  • 217
    O'Toole D, Nahon–Uzan K, Ruszniewski P, Lévy P. Reply. Clin. Gastroenterol. Hepatol. 2006; 4: 802.
  • 218
    Taniguchi T, Kobayashi H, Fukui S, Ogura K, Saiga T, Okamoto M. A case of multifocal fibrosclerosis involving posterior mediastinal fibrosis, retroperitoneal fibrosis, and a left seminal vesicle with elevated serum IgG4. Hum. Pathol. 2006; 37: 12379.
  • 219
    Leclercq P, Meurisse N, Honore P. Autoimmune pancreatitis. N. Engl. J. Med. 2007; 356: 15867.
  • 220
    Chari ST, Echelmeyer S. Can histopathology be the ‘gold standard’ for diagnosing autoimmune pancreatitis? Gastroenterology 2005; 129: 211820.
  • 221
    Kamisawa T. Clinical subtypes of autoimmune pancreatitis. Intern. Med. 2005; 44: 7856.
  • 222
    Kamisawa T. IgG4-related sclerosing disease. Intern. Med. 2006; 45: 1256.
  • 223
    Kamisawa T. Is it time to reconsider autoimmune pancreatitis? J. Gastroenterol. 2006; 41: 12401.
  • 224
    Okazaki K. Is IgG4-associated multifocal systemic fibrosis the same disease entity as autoimmune pancreatitis? Intern. Med. 2007; 46: 11718.
  • 225
    Chari ST. Current concepts in the treatment of autoimmune pancreatitis. JOP 2007; 8: 13.
  • 226
    ASHP Commission on Therapeutics. ASHP therapeutic guidelines for intravenous immune globulin. Clin. Pharm. 1992; 11: 11736.
  • 227
    Gugler E, Pallavicini JC, Swedlow H, Zipkin I, Agnese PA. Immunological studies of submaxillary saliva from patients with cystic fibrosis and from normal children. J. Pediatr. 1968; 73: 54859.
  • 228
    Kriebel GW Jr, Kraft SC, Rothberg RM. Locally produced antibody in human gastrointestinal secretions. J. Immunol. 1969; 103: 126875.
  • 229
    Bowman BH, McCombs ML, Lockhart LH. Cystic fibrosis: characterization of the inhibitor to ciliary action in oyster gills. Science 1970; 167: 8713.
  • 230
    Jones CE Jr, Alexander JW, Fisher MW. Clinical evaluation of Pseudomonas hyperimmune globulin and plasma. Surg. Forum 1970; 21: 23840.
  • 231
    Gupta RK. Immunohistochemical study of glomerular lesions in acute pancreatitis. Arch. Pathol. 1971; 92: 26772.
  • 232
    Rule AH, Lawrence D, Hager HJ, Hyslop N Jr, Shwachman H. IgA presence in meconium obtained from patients with cystic fibrosis. Pediatrics 1971; 48: 6014.
  • 233
    Doggett RG, Harrison GM. Pseudomonas aeruginosa: immune status in patients with cystic fibrosis. Infect. Immun. 1972; 6: 62835.
  • 234
    Felgenhauer K, Alzer G, Schumacher K. Monoclonal immunoglobulins on disc electrophoresis. Klin. Wochenschr. 1972; 50: 10336.
  • 235
    Serrano-Ríos M, Mato J, Oya M, Larrodera L, Hawkins F, Escobar F. Failure to find IgG insulin antibodies in Down's syndrome. Horm. Metab. Res. 1973; 5: 578.
  • 236
    Herzberg V, Calvert L, Bowman BH. Evidence that the ciliary inhibitor of cystic fibrosis is not an antibody. J. Clin. Invest. 1973; 52: 27326.
  • 237
    Danes BS, Litwin SD, Hütteroth TH, Cleve H, Bearn AG. Characterization of cystic fibrosis factor and its interaction with human immunoglobulin. J. Exp. Med. 1973; 137: 153843.
  • 238
    Khan MA, Litt M, Kwart H, Rosenlund ML. Measurement of colloid zeta potential as a test for cystic fibrosis secretion factor. Tex. Rep. Biol. Med. 1973; 31: 66583.
  • 239
    Barnett DR, Schanfield MS, McCombs ML, Bowman BH. Isoelectric focusing and IgG allotyping of the serum fraction containing the cystic fibrosis ciliary inhibitor. Tex. Rep. Biol. Med. 1973; 31: 70914.
  • 240
    Rachelefsky GS, Osher A, Dooley RE, Ank B, Stiehm ER. Coexistent respiratory allergy and cystic fibrosis. Am. J. Dis. Child 1974; 128: 3559.
  • 241
    Bozkowa K, Golebiowska H, Lambert I, Kunicka A, Duros H, Nowakowska A. Immunological studies in children with cystic fibrosis (C.F.). Boll. Ist. Sieroter. Milan. 1974; 53 (Suppl. 1): 266.
  • 242
    Geokas MC, Wollesen F, Rinderknecht H. Radioimmunoassay for pancreatic carboxypeptidase B in human serum. J. Lab. Clin. Med. 1974; 84: 57483.
  • 243
    Wilson GB, Jahn TL. Decreased rate of cytolysis of Colpidium striatum by cystic fibrosis serum I. Bioassay and evidence for the possible involvement of a C/F factor–IgG complex. Life Sci. 1974; 15: 55167.
  • 244
    McCrae WM, Raeburn JA. The patterns of infection in cystic fibrosis. Scott. Med. J. 1974; 19: 18790.
  • 245
    Feigelson J, Pecau Y, Cathelineau L, Navarro J. Additional data on hepatic function tests in cystic fibrosis. Acta Paediatr. Scand. 1975; 64: 33744.
  • 246
    Brasher GW, Dyck WP, Hall FF, Spiekerman AM. Immunoglobulin characterization of human pancreatic fluid. Am. J. Dig. Dis. 1975; 20: 4549.
  • 247
    Sorenson RL, Shank RD, Elde RP. Immunoperoxidase demonstration of human serum globulin binding to islet tissue. Diabetes 1975; 24: 2307.
  • 248
    Lendrum R, Walker G. Serum antibodies in human pancreatic disease. Gut 1975; 16: 36571.
  • 249
    Altland K, Schmidt SR, Kaiser G, Knoche W. Demonstration of a factor in the serum of homozygotes and heterozygotes for cystic fibrosis by a non-biological technique. Humangenetik 1975; 28: 20716.
  • 250
    Arad I, Lafair JS, Shapira E. Application of the cilia dyskinesis test in the diagnosis of cystic fibrosis in an adolescent. Isr. J. Med. Sci. 1975; 11: 1014.
  • 251
    Maclaren NK, Huang SW, Fogh J. Antibody to cultured human insulinoma cells in insulin-dependent diabetes. Lancet 1975; 1: 9971000.
  • 252
    Wilson GB, Fudenberg HH, Jahn TL. Studies on cystic fibrosis using isoelectric focusing I. An assay for detection of cystic fibrosis homozygotes and heterozygote carriers from serum. Pediatr. Res. 1975; 9: 63540.
  • 253
    Conod EJ, Conover JH, Hirschhorn K. Demonstration of human leukocyte degranulation induced by sera from homozygotes and heterozygotes for cystic fibrosis. Pediatr. Res. 1975; 9: 7249.
  • 254
    Siwinska-Golebiowska H. Studies on immunoglobulins in healthy children in various stages of development and in the chosen illnesses. Probl. Med. Wieku Rozwoj. 1975; 4: 20714.
  • 255
    Høiby N, Wiik A. Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis. Scand. J. Respir. Dis. 1975; 56: 3846.
  • 256
    Brogan TD, Ryley HC, Neale L, Yassa J. Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis. Thorax 1975; 30: 729.
  • 257
    Shakib F, Stanworth DR, Smalley CA, Brown GA. Elevated serum IgG4 levels in cystic fibrosis patients. Clin. Allergy 1976; 6: 23740.
  • 258
    Hann S, Holsclaw DS. Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum. Infect. Immun. 1976; 14: 11417.
  • 259
    Lorin MI, Gaerlan PF, Mandel ID, Denning CR. Composition of nasal secretion in patients with cystic fibrosis. J. Lab. Clin. Med. 1976; 88: 11417.
  • 260
    Newhouse MT, Rossman CM, Dolovich J, Dolovich MB, Wilson WM. Impairment of mucociliary transport in cystic fibrosis. Mod. Probl. Paediatr. 1976; 19: 1908.
  • 261
    Zegers BJ, Maertzdorf WJ, Van Loghem E et al. Kappa-chain deficiency. An immunoglobulin disorder. N. Engl. J. Med. 1976; 294: 102630.
  • 262
    Carson SD, Harper BL, Barnett DR, Kurosky A, Lankford BJ, Bowman BH. Electrophoretic studies of the cystic fibrosis ciliary inhibitor and its interaction with immunoglobulin G. Tex. Rep. Biol. Med. 1976; 34: 21019.
  • 263
    Conover JH, Conod EJ, Hirschhorn K. On the nature of the defect in cystic fibrosis. Tex. Rep. Biol. Med. 1976; 34: 4550.
  • 264
    Harper BL, Barnett DR, Bissett JD. Immunochemical studies of the plasma and cultured fibroblast media fractions containing the cystic fibrosis ciliary inhibitor. Tex. Rep. Biol. Med. 1976; 34: 7382.
  • 265
    Clarke CW. Aspects of serum and sputum antibody in chronic airways obstruction. Thorax 1976; 31: 7027.
  • 266
    Wilson GB, Fudenberg HH. Studies on cystic fibrosis using isoelectric focusing IV. Distinction between ciliary dyskinesia activity in cystic fibrosis and asthmatic sera and association of cystic fibrosis protein with the activity in cystic fibrosis serum. Pediatr. Res. 1977; 11: 31724.
  • 267
    Wilson GB, Monsher MT, Fudenberg HH. Studies on cystic fibrosis using isoelectric focusing III. Correlation between cystic fibrosis protein and ciliary dyskinesia activity in serum shown by a modified rabbit tracheal bioassay. Pediatr. Res. 1977; 11: 1436.
  • 268
    Conod EJ, Conover JH, Gaerlan P. Separation of serum ciliary dyskinesia substances from cystic fibrosis subjects. Pediatr. Res. 1977; 11: 457.
  • 269
    Thomas JM, Merritt AD, Hodes ME. Electrophoretic analysis of serum proteins in cystic fibrosis. Pediatr. Res. 1977; 11: 114854.
  • 270
    Antal L, Kávai M, Várhelyi I, Szegedi G. Abnormalities in humoral and cellular immune activity in pancreatitis I. Study of the humoral immune system. Acta Med. Acad. Sci. Hunga. 1978; 35: 6979.
  • 271
    Antal L, Szabó G, Sonkoly S, Pálóczi K, Szegedi G. Abnormalities in humoral and cellular immunoactivity in pancreatitis. II. Study of the cellular immune system. Acta Med. Acad. Sci. Hunga. 1978; 35: 817.
  • 272
    Schiøtz PO, Nielsen H, Høiby N, Glikmann G, Svehag SE. Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection. Acta Pathol. Microbiol. Scand. [C 1978; 86: 3740.
  • 273
    Wilson GB, Fudenberg HH. Separation of ciliary dyskinesia substances found in serum and secreted by cystic fibrosis leukocytes and lymphoid cell lines, using protein A–Sepharose CL-4B. J. Lab. Clin. Med. 1978; 92: 46382.
  • 274
    Kelly RH, Rao KN, Harvey VS, Lombardi B. Acute hemorrhagic pancreatic necrosis in mice: lack of a pathogenetic role for complement. Acta Hepatogastroenterol. Stuttg. 1979; 26: 3029.
  • 275
    Schiøtz PO, Høiby N, Permin H, Wiik A. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis. Acta Pathol. Microbiol. Scand. [C 1979; 87C: 22933.
  • 276
    Schiøtz PO, Egeskjold EM, Høiby N, Permin H. Autoantibodies in serum and sputum from patients with cystic fibrosis. Acta Pathol. Microbiol. Scand. [C 1979; 87: 31924.
  • 277
    Carswell F, Oliver J, Silverman M. Allergy in cystic fibrosis. Clin. Exp. Immunol. 1979; 35: 1416.
  • 278
    Romeo G, Parsons M, Bossen A, Blessing-Moore J, Cavalli-Sforza LL. Binding of 125I-labeled proteinases to plasma proteins in cystic fibrosis. Pediatr. Res. 1979; 13: 10306.
  • 279
    Gawel J, Rudnik J, Pryjma J et al. Proteins in bronchial secretion of children with chronic pulmonary diseases I. Relation to clinical diagnosis. Scand. J. Respir. Dis. 1979; 60: 638.
  • 280
    Zebrak J, Herman T, Werys R, Pryjma J, Gawel J. Proteins in bronchial secretion of children with chronic pulmonary diseases II. Relation to bronchoscopic and bronchographic examination. Scand. J. Respir. Dis. 1979; 60: 6975.
  • 281
    Fasth A, Kollberg H. Autoantibodies to Tamm-Horsfall protein in patients with cystic fibrosis. Acta Paediatr. Scand. 1980; 69: 18992.
  • 282
    Schiøtz PO, Clemmensen I, Høiby N. Immunoglobulins and albumin in sputum from patients with cystic fibrosis. A study of protein stability and presence of proteases. Acta Pathol. Microbiol. Scand. [C 1980; 88: 27580.
  • 283
    Møller NE, Ahlstedt S, Skov PS, Norn S. Allergological examination of cystic fibrosis patients with skin reactions during carbenicillin treatment. Allergy 1980; 35: 1358.
  • 284
    Shapira E, Menendez R. Increased binding of concanavalin A to alpha 2-macroglobulin, IgM and IgG from cystic fibrosis plasma. Biochem. Biophys. Res. Commun. 1980; 93: 506.
  • 285
    Räisänen SM, Suni JI, Leinikki P. Serological diagnosis of Mycoplasma pneumoniae infection by enzyme immunoassay. J. Clin. Pathol. 1980; 33: 83640.
  • 286
    Fick RB Jr, Naegel GP, Reynolds HY. Use of Pseudomonas aeruginosa lipopolysaccharide immunoadsorbents to prepare high potency, mono-specific antibodies. J. Immunol. Methods 1980; 38: 10316.
  • 287
    Manson JC, Brock DJ. Development of a quantitative immunoassay for the cystic fibrosis gene. Lancet 1980; 1: 3301.
  • 288
    Matthews WJ Jr, Williams M, Oliphint B, Geha R, Colten HR. Hypogammaglobulinemia in patients with cystic fibrosis. N. Engl. J. Med. 1980; 302: 2459.
  • 289
    Berdischewsky M, Pollack M, Young LS, Chia D, Osher AB, Barnett EV. Circulating immune complexes in cystic fibrosis. Pediatr. Res. 1980; 14: 8303.
  • 290
    Kurlandsky LE, Berninger RW, Talamo RC. Mucus-stimulating activity in the sera of patients with cystic fibrosis: demonstration and preliminary fractionation. Pediatr. Res. 1980; 14: 12638.
  • 291
    Tobin MJ, Maguire O, Reen D, Tempany E, Fitzgerald MX. Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax 1980; 35: 80713.
  • 292
    Moss RB, Hsu YP, Lewiston NJ. 125I-Clq-binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosis. J. Pediatr. 1981; 99: 21522.
  • 293
    Moss RB, Hsu YP. Isolation and characterization of circulating immune complexes in cystic fibrosis. Clin. Exp. Immunol. 1982; 47: 3018.
  • 294
    Owens-Williams L, Shapira E. Increased binding of limulin to alpha 2-macroglobulin and immunoglobulin M from cystic fibrosis patients. J. Pediatr. Gastroenterol. Nutr. 1982; 1: 56770.
  • 295
    Margolies R, Gray B, Boat TF. Identification of a major heparin-precipitable protein in human serum and its relationship to cystic fibrosis. Pediatr. Res. 1982; 16: 1816.
  • 296
    Blitzer MG, Shapira E. A purified serum glycopeptide from controls and cystic fibrosis patients II. Comparison of their immunologic properties using monoclonal antibodies. Pediatr. Res. 1982; 16: 93842.
  • 297
    Fick RB, Reynolds HY. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody? Bull. Eur. Physiopathol. Respir. 1983; 19: 15161.
  • 298
    Hsu YP, Moss RB. Microtiter immunoenzymatic assay (micro-ELISA) for antigen-specific IgG4 subclass antibody. Clin. Rev. Allergy 1983; 1: 2316.
  • 299
    Borsey DQ, Di Mario U, Irvine WJ et al. Humoral immunity in type 1 diabetes mellitus: a prospective study. J. Clin. Lab. Immunol. 1983; 11: 915.
  • 300
    Penketh AR, Pitt TL, Hodson ME, Batten JC. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa. J. Med. Microbiol. 1983; 16: 4018.
  • 301
    Margolies R, Boat TF. The carbohydrate content of IgG from patients with cystic fibrosis. Pediatr. Res. 1983; 17: 9315.
  • 302
    Schulz G, Bumol TF, Reisfeld RA. Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 1983; 80: 540711.
  • 303
    Granström M, Ericsson A, Strandvik B et al. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatr. Scand. 1984; 73: 7727.
  • 304
    Olds LC, Miller JJ III. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases. Arthritis Rheum 1984; 27: 3306.
  • 305
    Parsa I, Reddy JK. Alteration of a membrane associated marker in transplantable rat pancreatic acinar cell carcinoma. Carcinogenesis 1984; 5: 70913.
  • 306
    Sanderson MJ, Sleigh MA. The effects of serum immunoglobulins on the metachronal coordination of the lateral cilia of Mytilus edulis. Cell Motil. 1984; 4: 10319.
  • 307
    Davis CA, Abramowsky CR, Swinehart G. Circulating immune complexes and the nephropathy of cystic fibrosis. Hum. Pathol. 1984; 15: 2447.
  • 308
    Fick RB Jr, Naegel GP, Squier SU, Wood RE, Gee JB, Reynolds HY. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J. Clin. Invest. 1984; 74: 23648.
  • 309
    Pier GB, Elcock ME. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa. J. Immunol. 1984; 133: 7349.
  • 310
    Wheeler WB, Williams M, Matthews WJ Jr, Colten HR. Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. J. Pediatr. 1984; 104: 6959.
  • 311
    Schønheyder H, Jensen T, Høiby N, Andersen P, Koch C. Frequency of Aspergillus fumigatus isolates and antibodies to Aspergillus antigens in cystic fibrosis. Acta Pathol. Microbiol. Immunol. Scand. [B] 1985; 93: 10512.
  • 312
    Fick RB Jr, Baltimore RS, Squier SU, Reynolds HY. IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis. J. Infect. Dis. 1985; 151: 58998.
  • 313
    Singh G, Das SN, Khanna NN. Immune status in advanced upper gastrointestinal cancers. J. Surg. Oncol. 1985; 29: 435.
  • 314
    Ohshio G, Furukawa F, Manabe T, Tobe T, Hamashima Y. Single stranded DNA binding antibodies in patients with obstructive jaundice. Jpn J. Surg. 1985; 15: 11822.
  • 315
    Auerbach HS, Williams M, Kirkpatrick JA, Colten HR. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 1985; 2: 6868.
  • 316
    Børkje B, Vetvik K, Odegaard S, Schrumpf E, Larssen TB, Kolmannskog F. Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative colitis. Scand. J. Gastroenterol. 1985; 20: 53942.
  • 317
    Ericsson A, Granström M, Möllby R, Strandvik B. Antibodies to staphylococcal teichoic acid and alpha toxin in patients with cystic fibrosis. Acta Paediatr. Scand. 1986; 75: 13944.
  • 318
    Moss RB, Hsu YP, Lewiston NJ et al. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis. Am. Rev. Respir. Dis. 1986; 133: 64852.
  • 319
    Fick RB Jr, Olchowski J, Squier SU, Merrill WW, Reynolds HY. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide. Am. Rev. Respir. Dis. 1986; 133: 41822.
  • 320
    Brett MM, Ghoneim AT, Littlewood JM. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Arch. Dis. Child 1986; 61: 111420.
  • 321
    Moore DJ, Largman C, Kopelman HR, Wong S, Durie PR. Abnormalities of circulating immunoreactive pancreatic anionic trypsinogen in cystic fibrosis: an assay artifact due to cross-reacting serum antibodies. Clin. Biochem. 1986; 19: 3037.
  • 322
    Herlyn D, Sears H, Iliopoulos D et al. Anti-idiotypic antibodies to monoclonal antibody CO17-1A. Hybridoma 1986; 5 (Suppl. 1): S518.
  • 323
    Negishi K, Kawazu S, Ishii J, Kanazawa Y. Quantitative estimation of islet cell surface antibodies in sera of patients with diabetes mellitus, using BK virus-induced insulinoma, rat islet or fish islet cells and 125I-antihuman IgG antibody. J. Clin. Lab. Immunol. 1986; 19: 1559.
  • 324
    Shryock TR, Mollé JS, Klinger JD, Thomassen MJ. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis. J. Clin. Microbiol. 1986; 23: 51316.
  • 325
    Brett MM, Ghoneim AT, Littlewood JM, Losowsky MS. Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis. J. Clin. Pathol. 1986; 39: 11249.
  • 326
    Laroche D, Jezequel M, Travert G. Trypsin-binding immunoglobulin G in cystic fibrosis, allergic, and normal children. J. Pediatr. Gastroenterol. Nutr. 1986; 5: 4047.
  • 327
    Disis ML, McDonald TL, Colombo JL, Kobayashi RH, Angle CR, Murray S. Circulating immune complexes in cystic fibrosis and their correlation to clinical parameters. Pediatr. Res. 1986; 20: 38590.
  • 328
    Moss RB, Hsu YP, Sullivan MM, Lewiston NJ. Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency. Pediatr. Res. 1986; 20: 4539.
  • 329
    Baltimore RS, Fick RB Jr, Fino L. Antibody to multiple mucoid strains of Pseudomonas aeruginosa in patients with cystic fibrosis, measured by an enzyme-linked immunosorbent assay. Pediatr. Res. 1986; 20: 108590.
  • 330
    Brett MM, Ghoneim AT, Littlewood JM. Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection. Arch. Dis. Child 1987; 62: 35761.
  • 331
    Hollsing AE, Granström M, Strandvik B. Prospective study of serum staphylococcal antibodies in cystic fibrosis. Arch. Dis. Child 1987; 62: 90511.
  • 332
    Moss RB. Hypergammaglobulinemia in cystic fibrosis. Role of Pseudomonas endobronchial infection. Chest 1987; 91: 5226.
  • 333
    Przyklenk B, Bauernfeind A, Hörl G, Emminger G. Serologic response to Candida albicans and Aspergillus fumigatus in cystic fibrosis. Infection 1987; 15: 30810.
  • 334
    Pedersen SS, Espersen F, Høiby N. Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1987; 25: 18306.
  • 335
    Hollsing AE, Granström M, Vasil ML, Wretlind B, Strandvik B. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. J. Clin. Microbiol. 1987; 25: 186874.
  • 336
    Moss RB, Hsu YP, Van Eede PH, Van Leeuwen AM, Lewiston NJ, De Lange G. Altered antibody isotype in cystic fibrosis: impaired natural antibody response to polysaccharide antigens. Pediatr. Res. 1987; 22: 70813.
  • 337
    Leino R, Granfors K, Havia T, Heinonen R, Lampinen M, Toivanen A. Yersiniosis as a gastrointestinal disease. Scand. J. Infect. Dis. 1987; 19: 638.
  • 338
    Pressler T, Mansa B, Jensen T, Pedersen SS, Høiby N, Koch C. Increased IgG2 and IgG3 concentration is associated with advanced Pseudomonas aeruginosa infection and poor pulmonary function in cystic fibrosis. Acta Paediatr. Scand. 1988; 77: 57682.
  • 339
    Forsyth KD, Hohmann AW, Martin AJ, Bradley J. IgG antibodies to Aspergillus fumigatus in cystic fibrosis: a laboratory correlate of disease activity. Arch. Dis. Child 1988; 63: 9537.
  • 340
    Van Bever HP, Gigase PL, De Clerck LS, Bridts CH, Franckx H, Stevens WJ. Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis. Arch. Dis. Child 1988; 63: 12228.
  • 341
    Bosslet K, Büchler M, Klapdor R, Muhrer C, Sedlacek HH, Schulz G. Human monoclonal anti-idiotypic antibodies as an epitope vaccine against pancreatic carcinoma. Behring Inst. Mitt. 1988; 82: 1936.
  • 342
    Hodson ME, Morris L, Batten JC. Serum immunoglobulins and immunoglobulin G subclasses in cystic fibrosis related to the clinical state of the patient. Eur. Respir. J. 1988; 1: 7015.
  • 343
    Knutsen AP, Slavin RG, Roodman ST, Mueller KR, Marino NL. Decreased T helper cell function in patients with cystic fibrosis. Int. Arch. Allergy Appl. Immunol. 1988; 85: 20812.
  • 344
    Bosslet K, Döring N, Seemann G, Schulz G, Sedlacek HH. Immunological tailoring of monoclonal antibodies for immunotherapy of pancreatic carcinoma. Int. J. Cancer Suppl. 1988; 2: 858.
  • 345
    Schulz G, Büchler M, Muhrer KH et al. Immunotherapy of pancreatic cancer with monoclonal antibody BW 494. Int. J. Cancer Suppl. 1988; 2: 8994.
  • 346
    Brett MM, Ghoneim AT, Littlewood JM. Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study. J. Clin. Microbiol. 1988; 26: 156570.
  • 347
    Aronoff SC, Stern RC. Serum IgG antibody to outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis. J. Infect. Dis. 1988; 157: 93440.
  • 348
    Moss RB. The role of IgG subclass antibodies in chronic infection: the case of cystic fibrosis. N. Engl. Reg. Allergy Proc. 1988; 9: 5761.
  • 349
    Schidlow DV, Panitch HB, Zaeri N, Zenel J, Alpert BE. Purpuric rashes in cystic fibrosis. Am. J. Dis. Child 1989; 143: 10302.
  • 350
    Suter S, Schaad UB, Roux-Lombard P, Girardin E, Grau G, Dayer JM. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am. Rev. Respir. Dis. 1989; 140: 16404.
  • 351
    Albus A, Saalmann M, Tesch H, Pedersen SS, Döring G. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis. APMIS 1989; 97: 11468.
  • 352
    Lahat N, Rivlin J, Iancu TC. Functional immunoregulatory T-cell abnormalities in cystic fibrosis patients. J. Clin. Immunol. 1989; 9: 28795.
  • 353
    Eichler I, Joris L, Hsu YP, Van Wye J, Bram R, Moss R. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. J. Clin. Invest. 1989; 84: 1794804.
  • 354
    Lagacé J, Mercier J, Fréchette M et al. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis. J. Clin. Lab. Immunol. 1989; 30: 711.
  • 355
    Anderson TR, Montie TC, Murphy MD, McCarthy VP. Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis. J. Clin. Microbiol. 1989; 27: 278993.
  • 356
    Fomsgaard A, Dinesen B, Shand GH, Pressler T, Høiby N. Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. J. Clin. Microbiol. 1989; 27: 12229.
  • 357
    Shearman CP, Gosling P, Walker KJ. Is low proteinuria an early predictor of severity of acute pancreatitis? J. Clin. Pathol. 1989; 42: 11325.
  • 358
    Knutsen AP, Slavin RG. In vitro T cell responses in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis. J. Lab. Clin. Med. 1989; 113: 42835.
  • 359
    Bainbridge T, Fick RB Jr. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase. J. Lab. Clin. Med. 1989; 114: 72833.
  • 360
    Blandin C, Laroche D, Lemonnier F, Pasquet C, Travert G. Trypsin-binding immunoglobulin G and associated antigen in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 1989; 9: 1316.
  • 361
    Winnie GB, Cowan RG, Wade NA. Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis. J. Pediatr. 1989; 114: 30914.
  • 362
    Edwards JH, Alfaham M, Fifield R, Philpot C, Clement MJ, Goodchild MC. Sequential serological responses to Aspergillus fumigatus in patients with cystic fibrosis. Use of antigen ‘stretching’ to delineate IgG and IgE activity. Clin. Exp. Immunol. 1990; 81: 1018.
  • 363
    Pressler T, Pedersen SS, Espersen F, Høiby N, Koch C. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Pseudomonas aeruginosa infection investigated by ELISA. Clin. Exp. Immunol. 1990; 81: 42834.
  • 364
    Saitoh T, Fujiwara M, Asakura H. Ductal lesions of exocrine glands and insulitis induced by L3T4+ T cells following graft-versus-host reaction due to major histocompatibility complex class II disparity. Clin. Immunol. Immunopathol. 1990; 57: 33950.
  • 365
    Oberg C, Welsh N. Nonspecific delivery of substances into pancreatic islet cells by pH-sensitive liposomes in vitro. Diabete Metab. 1990; 16: 4854.
  • 366
    Emilie D, Crevon MC, Chicheportiche R et al. Cystic fibrosis patients' B-lymphocyte response is resistant to the in vitro enhancing effect of corticosteroids. Eur. J. Clin. Invest. 1990; 20: 6206.
  • 367
    Strandvik B, Hollsing A, Möllby R, Granström M. Antistaphylococcal antibodies in cystic fibrosis. Infection 1990; 18: 1702.
  • 368
    Reber S, Matzku S, Günthert U, Ponta H, Herrlich P, Zöller M. Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int. J. Cancer 1990; 46: 91927.
  • 369
    Hornick DB, Fick RB Jr. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion. J. Clin. Invest. 1990; 86: 128592.
  • 370
    Pedersen SS, Espersen F, Høiby N, Jensen T. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis. J. Clin. Microbiol. 1990; 28: 74755.
  • 371
    Knutsen AP, Hutcheson PS, Mueller KR, Slavin RG. Serum immunoglobulins E and G anti Aspergillus fumigatus antibody in patients with cystic fibrosis who have allergic bronchopulmonary aspergillosis. J. Lab. Clin. Med. 1990; 116: 7247.
  • 372
    Van Wye JE, Collins MS, Baylor M et al. Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis. Pediatr. Pulmonol. 1990; 9: 718.
  • 373
    Schaad UB, Lang AB, Wedgwood J, Buehlamnn U, Fuerer E. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity. Pediatr. Res. 1990; 27: 50813.
  • 374
    Johansen HK, Høiby N, Pedersen SS. Experimental immunization with Pseudomonas aeruginosa alginate induces IgA and IgG antibody responses. APMIS 1991; 99: 10618.
  • 375
    Asada H, Shibata K, Uchida K et al. Presence of human immunoglobulin G anti serum pancreatic elastase 1 autoantibodies and their influence on elastase 1 radioimmunoassay. Biochim. Biophys. Acta 1991; 1080: 349.
  • 376
    Johansson C, Nilsson O, Lindholm L. Comparison of serological expression of different epitopes on the CA50-carrying antigen CanAg. Int. J. Cancer 1991; 48: 75763.
  • 377
    Moss RB. Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis. J. Allergy Clin. Immunol. 1991; 87: 7888.
  • 378
    Hutcheson PS, Rejent AJ, Slavin RG. Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. J. Allergy Clin. Immunol. 1991; 88: 3904.
  • 379
    Schaad UB, Lang AB, Wedgwood J et al. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis. Lancet 1991; 338: 12367.
  • 380
    Couper R, Lichtman S, Cleghorn G, Del Castillo V, Durie P. Serum immunoglobulin G directed against porcine trypsin in pancreatic insufficient cystic fibrosis patients receiving pancreatic enzyme supplements. Pancreas 1991; 6: 55863.
  • 381
    Aronoff SC, Quinn FJ Jr, Stern RC. Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis. Pediatr. Pulmonol. 1991; 11: 28993.
  • 382
    Moss RB, McClelland E, Williams RR, Hilman BC, Rubio T, Adkinson NF. Evaluation of the immunologic cross-reactivity of aztreonam in patients with cystic fibrosis who are allergic to penicillin and/or cephalosporin antibiotics. Rev. Infect. Dis. 1991; 13 (Suppl. 7): S598607.
  • 383
    Niculescu F, Rus HG, Retegan M, Vlaicu R. Persistent complement activation on tumor cells in breast cancer. Am. J. Pathol. 1992; 140: 103943.
  • 384
    Cordon SM, Elborn JS, Rayner RJ, Hiller EJ, Shale DJ. IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis. Arch. Dis. Child 1992; 67: 73740.
  • 385
    Brett MM, Simmonds EJ, Ghoneim AT, Littlewood JM. The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis. Arch. Dis. Child 1992; 67: 10868.
  • 386
    Poccia F, Piselli P, Di Cesare S et al. Recognition and killing of tumour cells expressing heat shock protein 65 kD with immunotoxins containing saporin. Br. J. Cancer 1992; 66: 42732.
  • 387
    Pressler T, Pandey JP, Espersen F et al. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. Clin. Exp. Immunol. 1992; 90: 20914.
  • 388
    Bronson RA, O'Connor WJ, Wilson TA, Bronson SK, Chasalow FI, Droesch K. Correlation between puberty and the development of autoimmunity to spermatozoa in men with cystic fibrosis. Fertil. Steril. 1992; 58: 1199204.
  • 389
    Yassin N, Büchler M, Uhl W, Scherbaum WA. Antineutrophil cytoplasmic autoantibodies (ANCA) in acute pancreatitis. Hepatogastroenterology 1992; 39: 5335.
  • 390
    Sexton M, Reen DJ. Characterization of antibody-mediated inhibition of Pseudomonas aeruginosa adhesion to epithelial cells. Infect. Immun. 1992; 60: 33328.
  • 391
    Arruda LK, Platts-Mills TA, Longbottom JL, El-Dahr JM, Chapman MD. Aspergillus fumigatus: identification of 16, 18, and 45 kd antigens recognized by human IgG and IgE antibodies and murine monoclonal antibodies. J. Allergy Clin. Immunol. 1992; 89: 116676.
  • 392
    Sarkadi B, Bauzon D, Huckle WR et al. Biochemical characterization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis epithelial cells. J. Biol. Chem. 1992; 267: 208795.
  • 393
    Kronborg G, Fomsgaard A, Galanos C, Freudenberg MA, Høiby N. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients. J. Clin. Microbiol. 1992; 30: 184855.
  • 394
    Bruderer U, Cryz SJ Jr, Schaad UB, Deusinger M, Que JU, Lang AB. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients. J. Infect. Dis. 1992; 166: 3449.
  • 395
    Likavcanova E, Lagacé J. Quantitative analysis of immunoglobulin G subclass responses to Pseudomonas aeruginosa antigens in cystic fibrosis. J. Med. Microbiol. 1992; 36: 43744.
  • 396
    Chana T, Han X, Dagg B et al. TDM35—a new monoclonal antibody to the XH1 cervical carcinoma cell line. Characterization and immunoperoxidase localization in benign and malignant tissues. J. Pathol. 1992; 167: 3917.
  • 397
    Pressler T, Kronborg G, Shand GH, Mansa B, Høiby N. Determination of IgG subclass antibodies to Pseudomonas aeruginosa outer membrane proteins in cystic fibrosis lung infection using immunoblotting and enzyme-linked immunosorbent assay. Med. Microbiol. Immunol. 1992; 181: 33949.
  • 398
    Pressler T, Pedersen SS, Espersen F, Høiby N, Koch C. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection. Pediatr. Pulmonol. 1992; 14: 4451.
  • 399
    Loudovaris T, Charlton B, Hodgson RJ, Mandel TE. Destruction of xenografts but not allografts within cell impermeable membranes. Transpl. Proc. 1992; 24: 22912.
  • 400
    Bowler IM, Estlin EJ, Littlewood JM. Cystic fibrosis in Asians. Arch. Dis. Child 1993; 68: 1202.
  • 401
    Greally P, Hussain MJ, Vergani D, Price JF. Serum interleukin-1 alpha and soluble interleukin-2 receptor concentrations in cystic fibrosis. Arch. Dis. Child 1993; 68: 7857.
  • 402
    Windsor JA, Fearon KC, Ross JA et al. Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br. J. Surg. 1993; 80: 10426.
  • 403
    Brauner A, Cryz SJ, Granström M et al. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia. Eur. J. Clin. Microbiol. Infect. Dis. 1993; 12: 4306.
  • 404
    Kronborg G, Pressler T, Fomsgaard A, Koch C, Høiby N. Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis. Infection 1993; 21: 297302.
  • 405
    Martignat L, Feve B, Ouary M, Pogu S, Charbonnel B, Saï P. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells. J. Autoimmun. 1993; 6: 75369.
  • 406
    Hayward AR, Shriber M, Cooke A, Waldmann H. Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4. J. Autoimmun. 1993; 6: 30110.
  • 407
    Cowan RG, Winnie GB. Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis. J. Clin. Immunol. 1993; 13: 35970.
  • 408
    Weiner LM, Harvey E, Padavic-Shaller K et al. Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinoma. J. Immunother. Emphasis Tumor Immunol. 1993; 13: 11016.
  • 409
    Morrin M, Reen DJ. Inhibition of the adherence of Pseudomonas aeruginosa to epithelial cells by IgG subclass antibodies. J. Med. Microbiol. 1993; 39: 45966.
  • 410
    Morrin M, Reen DJ. Role of IgG subclass response to outer-membrane proteins in inhibiting adhesion of Pseudomonas aeruginosa to epithelial cells. J. Med. Microbiol. 1993; 39: 46772.
  • 411
    Nelson JW, Butler SL, Brown PH, Greening AP, Govan JR. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis. J. Med. Microbiol. 1993; 39: 3947.
  • 412
    Quirk P, Greer R, Shepherd R, Cleghorn G. Serum immunoglobulin G directed against porcine trypsin in the serum of cystic fibrosis children receiving porcine pancreatic enzyme supplements. J. Paediatr. Child Health 1993; 29: 196200.
  • 413
    Homnick DN, Cox JH, DeLoof MJ, Ringer TV. Carotenoid levels in normal children and in children with cystic fibrosis. J. Pediatr. 1993; 122: 7037.
  • 414
    Elborn JS, Cordon SM, Shale DJ. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis. Pediatr. Pulmonol. 1993; 15: 28791.
  • 415
    De Graeff-Meeder ER, Rijkers GT, Voorhorst-Ogink MM et al. Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr. Res. 1993; 34: 4248.
  • 416
    Feldman C, Weltman M, Wadee A, Sussman G, Smith C, Zwi S. A study of immunoglobulin G subclass levels in black and white patients with various forms of obstructive lung disease. S. Afr. Med. J. 1993; 83: 912.
  • 417
    Giwercman B, Rasmussen JW, Cioufu O, Clemmentsen I, Schumacher H, Høiby N. Antibodies against chromosomal beta-lactamase. Antimicrob. Agents Chemother. 1994; 38: 230610.
  • 418
    Greally P, Hussain MJ, Vergani D, Price JF. Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone. Arch. Dis. Child 1994; 71: 359.
  • 419
    Murali PS, Pathial K, Saff RH et al. Immune responses to Aspergillus fumigatus and Pseudomonas aeruginosa antigens in cystic fibrosis and allergic bronchopulmonary aspergillosis. Chest 1994; 106: 51319.
  • 420
    Hassan J, Feighery C, Bresnihan B, Keogan M, Fitzgerald MX, Whelan A. Serum IgA and IgG subclasses during treatment for acute respiratory exacerbation in cystic fibrosis: analysis of patients colonised with mucoid or non-mucoid strains of Pseudomonas aeruginosa. Immunol. Invest. 1994; 23: 113.
  • 421
    Knutsen AP, Mueller KR, Hutcheson PS, Slavin RG. Serum anti-Aspergillus fumigatus antibodies by immunoblot and ELISA in cystic fibrosis with allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 1994; 93: 92631.
  • 422
    Shennib H, Massard G, Reynaud M, Noirclerc M. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation. J. Heart Lung Transplant. 1994; 13: 51419.
  • 423
    Hostoffer RW, Krukovets I, Berger M. Enhancement by tumor necrosis factor-alpha of Fc alpha receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes. J. Infect. Dis. 1994; 170: 827.
  • 424
    Wulffraat NM, De Graeff-Meeder ER, Rijkers GT, Van Der Laag H, Kuis W. Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis. J. Pediatr. 1994; 125: 3748.
  • 425
    Lucarelli S, Quattrucci S, Zingoni AM et al. Food allergy in cystic fibrosis. Minerva Pediatr. 1994; 46: 5438.
  • 426
    Pressler T, Jensen ET, Espersen F, Pedersen SS, Høiby N, Koch C. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis. Pediatr. Pulmonol. 1994; 17: 3140.
  • 427
    Döring G, Krogh-Johansen H, Weidinger S, Høiby N. Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508. Pediatr. Pulmonol. 1994; 18: 37.
  • 428
    Berger M, Norvell TM, Tosi MF, Emancipator SN, Konstan MW, Schreiber JR. Tissue-specific Fc gamma and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa. Pediatr. Res. 1994; 35: 6877.
  • 429
    Nikolaizik WH, Moser M, Crameri R et al. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am. J. Respir. Crit. Care Med. 1995; 152: 6349.
  • 430
    Johansen HK, Nørgaard A, Andersen LP, Jensen P, Nielsen H, Høiby N. Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause false-positive titers of antibody to Helicobacter pylori. Clin. Diagn. Lab. Immunol. 1995; 2: 14955.
  • 431
    De Boeck K, Eggermont E, Smet M, Van Reempts P, Van Bever HP, Stevens WJ. Specific decrease of anti-pseudomonal IgA after anti-pseudomonal therapy in cystic fibrosis. Eur. J. Pediatr. 1995; 154: 15760.
  • 432
    Lacy DE, Smith AW, Stableforth DE, Smith G, Weller PH, Brown MR. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa. FEMS Immunol. Med. Microbiol. 1995; 10: 25361.
  • 433
    Bei R, Schlom J, Kashmiri SV. Baculovirus expression of a functional single-chain immunoglobulin and its IL-2 fusion protein. J. Immunol. Methods 1995; 186: 24555.
  • 434
    Lagacé J, Péloquin L, Kermani P, Montie TC. IgG subclass responses to Pseudomonas aeruginosa a- and b-type flagellins in patients with cystic fibrosis: a prospective study. J. Med. Microbiol. 1995; 43: 2706.
  • 435
    Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J. Pediatr. 1995; 126: 51523.
  • 436
    Croft NM, Marshall TG, Ferguson A. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet 1995; 346: 12657.
  • 437
    Pressler T, Jensen ET, Espersen F, Pedersen SS, Høiby N. High levels of complement-activation capacity in sera from patients with cystic fibrosis correlate with high levels of IgG3 antibodies to Pseudomonas aeruginosa antigens and poor lung function. Pediatr. Pulmonol. 1995; 20: 717.
  • 438
    Hutcheson PS, Knutsen AP, Rejent AJ, Slavin RG. A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis. Chest 1996; 110: 3636.
  • 439
    Magnelli V, Grassi C, Parlatore E, Sher E, Carbone E. Down-regulation of non-L-, non-N-type (Q-like) Ca2+ channels by Lambert-Eaton myasthenic syndrome (LEMS) antibodies in rat insulinoma RINm5F cells. FEBS Lett. 1996; 387: 4752.
  • 440
    Lee JE, Lowy AM, Thompson WA et al. Association of gastric adenocarcinoma with the HLA class II gene DQB10301. Gastroenterology 1996; 111: 42632.
  • 441
    Rosenecker J, Harms KH, Bertele RM et al. Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer. Infection 1996; 24: 58.
  • 442
    Ramiya VK, Shang XZ, Pharis PG et al. Antigen based therapies to prevent diabetes in NOD mice. J. Autoimmun. 1996; 9: 34956.
  • 443
    Holdsworth RJ, Parratt D. The potential role of Clostridium perfringens alpha toxin in the pathogenesis of acute pancreatitis. J. Clin. Pathol. 1996; 49: 5003.
  • 444
    Croft NM, Marshall TG, Ferguson A. Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis. Postgrad. Med. J. 1996; 72 (Suppl. 2): S326.
  • 445
    Zhao MH, Jayne DR, Ardiles LG, Culley F, Hodson ME, Lockwood CM. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM 1996; 89: 25965.
  • 446
    Petersen TD, Ciofu O, Pressler T, Giwercman B, Pedersen SS, Høiby N. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry. Thorax 1996; 51: 7338.
  • 447
    Ulanova M, Petersen TD, Ciofu O et al. The clonal antibody response to Pseudomonas aeruginosa heat shock protein is highly diverse in cystic fibrosis patients. APMIS 1997; 105: 44956.
  • 448
    Lee J, Ip W, Durie P. Is fibrosing colonopathy an immune mediated disease? Arch. Dis. Child 1997; 77: 6670.
  • 449
    Döring G, Dorner F. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis. Behring Inst. Mitt. 1997; 98: 33844.
  • 450
    Ciofu O, Pressler T, Pandey JP, Høiby N. The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients. Clin. Exp. Immunol. 1997; 108: 8894.
  • 451
    Lacy DE, Smith AW, Lambert PA et al. Serum IgG response to an outer membrane porin protein of Burkholderia cepacia in patients with cystic fibrosis. FEMS Immunol. Med. Microbiol. 1997; 17: 8794.
  • 452
    MacLean GD, Reddish MA, Longenecker BM. Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients. J. Immunother. 1997; 20: 708.
  • 453
    Eisenberg JD, Aitken ML, Dorkin HL, Harwood IR, Ramsey BW, Schidlow DV et al. Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. J. Pediatr. 1997; 131: 11824.
  • 454
    Niemann T, Larsen S, Mouritsen EA, Thorsgaard N. Helicobacter pylori infection in patients with chronic pancreatitis and duodenal ulcer. Scand. J. Gastroenterol. 1997; 32: 12013.
  • 455
    Al-Shamma MR, McSharry C, McLeod K, McCruden EA, Stack BH. Role of heat shock proteins in the pathogenesis of cystic fibrosis arthritis. Thorax 1997; 52: 10569.
  • 456
    Baraniuk JN, Clauw D, Yuta A et al. Nasal secretion analysis in allergic rhinitis, cystic fibrosis, and nonallergic fibromyalgia/chronic fatigue syndrome subjects. Am. J. Rhinol. 1998; 12: 43540.
  • 457
    Song Z, Kharazmi A, Wu H et al. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia. Clin. Diagn. Lab. Immunol. 1998; 5: 8827.
  • 458
    Kniola B, Hellström S, Ludvigsson J. Islet cell surface antibodies (ICSA) do bind to human pancreas: computerised, quantitative determination of ICSA using both pre- and postembedding immunocolloidal techniques. Diabetes Res. Clin. Pract. 1998; 39: 17383.
  • 459
    Preston MJ, Gerceker AA, Reff ME, Pier GB. Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide. Infect. Immun. 1998; 66: 413742.
  • 460
    Saito K, Ishikura H, Kishimoto T et al. Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: a possible event in tumor regression. Int. J. Cancer 1998; 75: 2849.
  • 461
    Sedivá A, Bartunková J, Kolárová I et al. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis. J. Autoimmun. 1998; 11: 18590.
  • 462
    Del Rosario MA, Fitzgerald JF, Chong SK, Croffie JM, Gupta SK. Further studies of anti-endomysium and anti-gliadin antibodies in patients with suspected celiac disease. J. Pediatr. Gastroenterol. Nutr. 1998; 27: 1915.
  • 463
    Giordano A, Magni A, Filadoro F, Graziani C, Quattrucci S, Cipriani P. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection. New Microbiol. 1998; 21: 3758.
  • 464
    Raderer M, Wrba F, Kornek G et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 1998; 55: 1619.
  • 465
    Dosanjh A, Theodore J, Pappagianis D. Probable false positive coccidioidal serologic results in patients with cystic fibrosis. Pediatr. Transplant. 1998; 2: 31317.
  • 466
    Foitzik T, Forgacs B, Ryschich E et al. Effect of different immunosuppressive agents on acute pancreatitis: a comparative study in an improved animal model. Transplantation 1998; 65: 10306.
  • 467
    Moser C, Hougen HP, Song Z, Rygaard J, Kharazmi A, Høiby N. Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response. APMIS 1999; 107: 1093100.
  • 468
    Chirmule N, Propert K, Magosin S, Qian Y, Qian R, Wilson J. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 1999; 6: 157483.
  • 469
    Ammori BJ, Leeder PC, King RF et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J. Gastrointest. Surg. 1999; 3: 25262.
  • 470
    Chang Y, Prud'homme GJ. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity. J. Gene Med. 1999; 1: 41523.
  • 471
    Ciofu O, Petersen TD, Jensen P, Høiby N. Avidity of anti-Pseudomonas aeruginosa antibodies during chronic infection in patients with cystic fibrosis. Thorax 1999; 54: 1414.
  • 472
    Skov M, Pressler T, Jensen HE, Høiby N, Koch C. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 1999; 54: 4450.
  • 473
    Smyth RL, Croft NM, O'Hea U, Marshall TG, Ferguson A. Intestinal inflammation in cystic fibrosis. Arch. Dis. Child 2000; 82: 3949.
  • 474
    Buttenschoen K, Berger D, Hiki N et al. Endotoxin and antiendotoxin antibodies in patients with acute pancreatitis. Eur. J. Surg. 2000; 166: 45966.
  • 475
    Mayer JM, Laine VJ, Gezgin A et al. Single doses of FK506 and OKT3 reduce severity in early experimental acute pancreatitis. Eur. J. Surg. 2000; 166: 73441.
  • 476
    Hahm KB, Im YH, Lee C et al. F-beta signaling contributes to autoimmune pancreatitis. J. Clin. Invest. 2000; 105: 105765.
  • 477
    Hendry J, Butler S, Elborn JS et al. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa. J. Infect. 2000; 40: 16470.
  • 478
    Aebi C, Theiler F, Aebischer CC, Schoeni MH. Autoantibodies directed against bactericidal/permeability-increasing protein in patients with cystic fibrosis: association with microbial respiratory tract colonization. Pediatr. Infect. Dis. J. 2000; 19: 20712.
  • 479
    Hendry J, Nixon L, Dodd M et al. Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia. Pediatr. Pulmonol. 2000; 29: 810.
  • 480
    Dror Y, Ginzberg H, Dalal I et al. Immune function in patients with Shwachman–Diamond syndrome. Br. J. Haematol. 2001; 114: 71217.
  • 481
    Hallay J, Kovács G, Szatmári K et al. Early jejunal nutrition and changes in the immunological parameters of patients with acute pancreatitis. Hepatogastroenterology 2001; 48: 148892.
  • 482
    Yano T, Ishikura H, Kato H et al. Vaccination effect of interleukin-6-producing pancreatic cancer cells in nude mice: a model of tumor prevention and treatment in immune-compromised patients. Jpn J. Cancer Res. 2001; 92: 837.
  • 483
    Jensen P, Johansen HK, Lanng S, Høiby N. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis. Pediatr. Res. 2001; 49: 4238.
  • 484
    Mitchell HM, Mascord K, Hazell SL, Daskalopoulos G. Association between the IgG subclass response, inflammation and disease status in Helicobacter pylori infection. Scand. J. Gastroenterol. 2001; 36: 14955.
  • 485
    Nikolaizik WH, Weichel M, Blaser K, Crameri R. Intracutaneous tests with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy. Am. J. Respir. Crit. Care Med. 2002; 165: 91621.
  • 486
    Miknyoczki SJ, Wan W, Chang H et al. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice. Clin. Cancer Res. 2002; 8: 192431.
  • 487
    Nakatsura T, Senju S, Ito M, Nishimura Y, Itoh K. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method. Eur. J. Immunol. 2002; 32: 82636.
  • 488
    Hallay J, Kovács G, Kiss Sz S, Farkas M, Lakos G, Sipka S et al. Changes in the nutritional state and immune-serological parameters of esophagectomized patients fed jejunaly with glutamine-poor and glutamine-rich nutriments. Hepatogastroenterology 2002; 49: 15559.
  • 489
    Maacke H, Hundertmark C, Miska S, Voss M, Kalthoff H, Stürzbecher HW. Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigen. J. Cancer Res. Clin. Oncol. 2002; 128: 21922.
  • 490
    Dittrich E, Schmaldienst S, Langer M, Jansen M, Hörl WH, Derfler K. Immunoadsorption and plasma exchange in pregnancy. Kidney Blood Press. Res. 2002; 25: 2329.
  • 491
    Karanikas G, Ulrich-Pur H, Becherer A et al. Uptake of indium-111-labeled human polyclonal immunoglobulin G in pancreatic cancer: in vivo and in vitro studies. Oncol. Rep. 2002; 9: 3537.
  • 492
    Petersson U, Borgström A, Ohlsson K, Fork FT, Toth E. Enzyme leakage, trypsinogen activation, and inflammatory response in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Pancreas 2002; 24: 3218.
  • 493
    Bose SM, Verma GR, Mazumdar A, Giridhar M, Ganguly NK. Significance of serum endotoxin and antiendotoxin antibody levels in predicting the severity of acute pancreatitis. Surg. Today 2002; 32: 6027.
  • 494
    Carlsson M, Eriksson L, Erwander I, Wieslander J, Segelmark M. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies. Clin. Exp. Rheumatol. 2003; 21 (6 Suppl. 32): S95100.
  • 495
    Watanabe S, Suzuki K, Kawauchi Y et al. Kinetic analysis of the development of pancreatic lesions in mice infected with a murine retrovirus. Clin. Immunol. 2003; 109: 21223.
  • 496
    Raithel M, Dormann H, Harsch IA et al. Immunoglobulin E production in chronic pancreatitis. Eur. J. Gastroenterol. Hepatol. 2003; 15: 8017.
  • 497
    Rahman SH, Ammori BJ, Larvin M, McMahon MJ. Increased nitric oxide excretion in patients with severe acute pancreatitis: evidence of an endotoxin mediated inflammatory response? Gut 2003; 52: 2704.
  • 498
    Hamanaka Y, Suehiro Y, Fukui M, Shikichi K, Imai K, Hinoda Y. Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer. Int. J. Cancer 2003; 103: 97100.
  • 499
    Gupta R, Patel K, Calder PC, Yaqoob P, Primrose JN, Johnson CD. A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHE II > or = 6). Pancreatology 2003; 3: 40613.
  • 500
    Terheggen-Lagro S, Truijens N, Van Poppel N, Gulmans V, Van Der Laag J, Van Der Ent C. Correlation of six different cystic fibrosis chest radiograph scoring systems with clinical parameters. Pediatr. Pulmonol. 2003; 35: 4415.
  • 501
    Ballmann M, Junge S, Von Der Hardt H. Low-dose methotrexate for advanced pulmonary disease in patients with cystic fibrosis. Respir. Med. 2003; 97: 498500.
  • 502
    Kawamoto S, Siegelman SS, Hruban RH, Fishman EK. Lymphoplasmacytic sclerosing pancreatitis with obstructive jaundice: CT and pathology features. AJR Am. J. Roentgenol. 2004; 183: 91521.
  • 503
    Balfour-Lynn IM, Mohan U, Bush A, Rosenthal M. Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children. Arch. Dis. Child 2004; 89: 31519.
  • 504
    Skov M, Pandey JP, Pressler T, Høiby N, Koch C. Immunoglobulin allotypes and IgG subclass antibody response to Aspergillus fumigatus in cystic fibrosis patients. J. Cyst. Fibros. 2004; 3: 1738.
  • 505
    Sloane AJ, Lindner RA, Prasad SS et al. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. Am. J. Respir. Crit. Care Med. 2005; 172: 141626.
  • 506
    Yamamoto K, Ueno T, Kawaoka T et al. MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer. Anticancer Res. 2005; 25: 35759.
  • 507
    Ramanathan RK, Lee KM, McKolanis J et al. Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer. Cancer Immunol. Immunother. 2005; 54: 25464.
  • 508
    Magnussen A, Kasman IM, Norberg S, Baluk P, Murray R, McDonald DM. Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels. Cancer Res. 2005; 65: 271221.
  • 509
    Suzuki H, Graziano DF, McKolanis J, Finn OJ. T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease. Clin. Cancer Res. 2005; 11: 15216.
  • 510
    Ferroni A, Sermet-Gaudelus I, Le Bourgeois M et al. Measurement of immunoglobulin G against mycobacterial antigen A60 in patients with cystic fibrosis and lung infection due to Mycobacterium abscessus. Clin. Infect. Dis. 2005; 40: 5866.
  • 511
    La Flamme KE, Mor G, Gong D et al. Nanoporous alumina capsules for cellular macroencapsulation: transport and biocompatibility. Diabetes Technol. Ther. 2005; 7: 68494.
  • 512
    Wakabayashi T, Kawaura Y, Satomura Y et al. Duct-narrowing chronic pancreatitis without immunoserologic abnormality: comparison with duct-narrowing chronic pancreatitis with positive serological evidence and its clinical management. Dig. Dis. Sci. 2005; 50: 141421.
  • 513
    Corvera CU, Blumgart LH, Darvishian F et al. Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J. Am. Coll. Surg. 2005; 201: 8629.
  • 514
    Moffatt SD, Demers P, Robbins RC et al. Lung transplantation: a decade of experience. J. Heart Lung Transplant. 2005; 24: 14551.
  • 515
    Condino AA, Hoffenberg EJ, Accurso F et al. Frequency of ASCA seropositivity in children with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 2005; 41: 236.
  • 516
    Hamelinck D, Zhou H, Li L et al. Optimized normalization for antibody microarrays and application to serum–protein profiling. Mol. Cell Proteomics 2005; 4: 77384.
  • 517
    Garside JP, Kerrin DP, Brownlee KG, Gooi HC, Taylor JM, Conway SP. Immunoglobulin and IgG subclass levels in a regional pediatric cystic fibrosis clinic. Pediatr. Pulmonol. 2005; 39: 13540.
  • 518
    Lammerts van Bueren JJ, Bleeker WK, Bøgh HO et al. Effect of target dynamics on pharmacokinetics of a novel therapeutic antibody against the epidermal growth factor receptor: implications for the mechanisms of action. Cancer Res. 2006; 66: 76308.
  • 519
    Nakahara T, Norberg SM, Shalinsky DR, Hu-Lowe DD, McDonald DM. Effect of inhibition of vascular endothelial growth factor signaling on distribution of extravasated antibodies in tumors. Cancer Res. 2006; 66: 143445.
  • 520
    Zuercher AW, Imboden MA, Jampen S et al. Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine. Clin. Exp. Immunol. 2006; 143: 1328.
  • 521
    Zuercher AW, Horn MP, Que JU et al. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis. FEMS Immunol. Med. Microbiol. 2006; 47: 3028.
  • 522
    Ueda T, Takeyama Y, Yasuda T et al. Immunosuppression in patients with severe acute pancreatitis. J. Gastroenterol. 2006; 41: 77984.
  • 523
    Pressler T, Frederiksen B, Skov M, Garred P, Koch C, Hoiby N. Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A case control study. J. Cyst. Fibros. 2006; 5: 915.
  • 524
    Tanaka M, Komatsu N, Yanagimoto Y et al. Development of a new diagnostic tool for pancreatic cancer: simultaneous measurement of antibodies against peptides recognized by cytotoxic T lymphocytes. Kurume Med. J. 2006; 53: 6370.
  • 525
    Barthet M, Lesavre N, Desplats S et al. Frequency and characteristics of pancreatitis in patients with inflammatory bowel disease. Pancreatology 2006; 6: 46471.
  • 526
    Yanagimoto H, Mine T, Yamamoto K et al. Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer. Cancer Sci. 2007; 98: 60511.
  • 527
    Griese M, Latzin P, Kappler M et al. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur. Respir. J. 2007; 29: 24050.
  • 528
    Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DY. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kB signaling, and HCV infection by standardized silymarin. Gastroenterology 2007; 132: 192536.
  • 529
    Ulla Rocha JL, Alvarez Sanchez MV, Paz Esquete J et al. Evaluation of the bilio-pancreatic region using endoscopic ultrasonography in patients referred with and without abdominal pain and CA 19-9 serum level elevation. JOP 2007; 8: 1917.
  • 530
    Tanaka M, Komatsu N, Terakawa N et al. Increased levels of IgG antibodies against peptides of the prostate stem cell antigen in the plasma of pancreatic cancer patients. Oncol. Rep. 2007; 18: 1616.
  • 531
    Triantopoulou C, Giannakou N, Delis S, Maniatis P, Manes K, Siafas I et al. Focal lymphoplasmacytic sclerosing pancreatitis—Radiological-pathological correlation. Pancreas 2007; 35: 1806.
  • 532
    Garside JP, Kerrin DP, Brownlee KG, Gooi HC, Taylor JM, Conway SP. Low gammaglobulin subclass 2 levels in paediatric cystic fibrosis patients followed over a 2-year period. Pediatr. Pulmonol. 2007; 42: 12530.
  • 533
    Levy H, Kalish LA, Huntington I et al. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr. Pulmonol. 2007; 42: 25662.
  • 534
    Bank S, Novis BH, Petersen E, Dowdle E, Marks IN. Serum immunoglobulins in calcific pancreatitis. Gut 1973; 14: 7235.
  • 535
    Soto J, Aufses AH Jr, Dreiling DA. The pancreas and immunoglobulins II. Immunoglobulin levels in the pancreatic secretions of patients with chronic pancreatitis. Am. J. Gastroenterol. 1977; 67: 5614.
  • 536
    Goodale RL Jr, Condie RM, Gajl-Peczalska K et al. Clinical and secretory differences in pancreatic cancer and chronic pancreatitis. Ann. Surg. 1981; 194: 1938.
  • 537
    Irie H, Honda H, Baba S et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am. J. Roentgenol. 1998; 170: 13237.
  • 538
    Kamisawa T, Funata N, Hayashi Y et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003; 52: 6837.
  • 539
    Kamisawa T, Funata N, Hayashi Y et al. A new clinicopathological entity of IgG4-related autoimmune disease. J. Gastroenterol. 2003; 38: 9824.
  • 540
    Hyodo N, Hyodo T. Ultrasonographic evaluation in patients with autoimmune-related pancreatitis. J. Gastroenterol. 2003; 38: 115561.
  • 541
    Saegusa H, Momose M, Kawa S et al. Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas 2003; 27: 205.
  • 542
    Zen Y, Harada K, Sasaki M et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am. J. Surg. Pathol. 2004; 28: 1193203.
  • 543
    Shinji A, Sano K, Hamano H et al. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest. Endosc. 2004; 59: 50611.
  • 544
    Farrell JJ, Garber J, Sahani D, Brugge WR. EUS findings in patients with autoimmune pancreatitis. Gastrointest. Endosc. 2004; 60: 92736.
  • 545
    Sahani DV, Kalva SP, Farrell J et al. Autoimmune pancreatitis: imaging features. Radiology 2004; 233: 34552.
  • 546
    Kitagawa S, Zen Y, Harada K et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Küttner's tumor). Am. J. Surg. Pathol. 2005; 29: 78391.
  • 547
    Kamisawa T, Egawa N, Nakajima H et al. Gastrointestinal findings in patients with autoimmune pancreatitis. Endoscopy 2005; 37: 112730.
  • 548
    Aoki S, Nakazawa T, Ohara H et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera. Histopathology 2005; 47: 14758.
  • 549
    Zen Y, Kitagawa S, Minato H et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum. Pathol. 2005; 36: 71017.
  • 550
    Nishino T, Toki F, Oyama H et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005; 30: 7682.
  • 551
    Ohara H, Nakazawa T, Sano H et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 2005; 31: 2327.
  • 552
    Chari ST, Smyrk TC, Levy MJ et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin. Gastroenterol. Hepatol. 2006; 4: 101016.
  • 553
    Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J. Gastroenterol. 2006; 41: 1197205.
  • 554
    Muraki T, Hamano H, Ochi Y et al. Autoimmune pancreatitis and complement activation system. Pancreas 2006; 32: 1621.
  • 555
    Kamisawa T, Tu Y, Nakajima H, Egawa N, Tsuruta K, Okamoto A. Usefulness of biopsying the major duodenal papilla to diagnose autoimmune pancreatitis: a prospective study using IgG4-immunostaining. World J. Gastroenterol. 2006; 12: 20313.
  • 556
    Kamisawa T, Tu Y, Nakajima H et al. Sclerosing cholecystitis associated with autoimmune pancreatitis. World J. Gastroenterol. 2006; 12: 37369.
  • 557
    Kojima M, Sipos B, Klapper W et al. Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells. Am. J. Surg. Pathol. 2007; 31: 5218.
  • 558
    Zen Y, Fujii T, Harada K et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007; 45: 153846.
  • 559
    Kamisawa T, Tu Y, Sasaki R, Egawa N, Kamata N, Sasaki T. The relationship of salivary gland function to elevated serum IgG4 in autoimmune pancreatitis. Intern. Med. 2007; 46: 4359.
  • 560
    Kawa S, Ota M, Yoshizawa K et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002; 122: 12649.
  • 561
    Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am. J. Gastroenterol. 2003; 98: 26949.
    Direct Link:
  • 562
    Yadav D, Notahara K, Smyrk TC et al. Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection. Clin. Gastroenterol. Hepatol. 2003; 1: 12935.
  • 563
    Hirano K, Shiratori Y, Komatsu Y et al. Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin. Gastroenterol. Hepatol. 2003; 1: 45364.
  • 564
    Weber SM, Cubukcu-Dimopulo O, Palesty JA et al. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J. Gastrointest. Surg. 2003; 7: 12937.
  • 565
    Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan; presence of a subgroup without pancreatic involvement in older patients. Hepatol. Res. 2004; 29: 1539.
  • 566
    Davidson TS, Longnecker DS, Hickey WF. An experimental model of autoimmune pancreatitis in the rat. Am. J. Pathol. 2005; 166: 72936.
  • 567
    Komatsu K, Hamano H, Ochi Y et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig. Dis. Sci. 2005; 50: 10527.
  • 568
    Yamamoto M, Harada S, Ohara M et al. Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome. Rheumatology 2005; 44: 22734.
  • 569
    Deshpande V, Chiocca S, Finkelberg D et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am. J. Surg. Pathol. 2006; 30: 153745.
  • 570
    Mendes FD, Jorgensen R, Keach J et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 2006; 101: 20705.
    Direct Link:
  • 571
    Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med. 2006; 4: 23.
  • 572
    Hirano K, Kawabe T, Komatsu Y et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern. Med. J. 2006; 36: 5861.
  • 573
    Nakazawa T, Ohara H, Sano H et al. Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest. Endosc. 2007; 65: 99108.
  • 574
    Nahon Uzan K, Levy P, O'Toole D et al. Is idiopathic chronic pancreatitis an autoimmune disease? Clin. Gastroenterol. Hepatol. 2005; 3: 9039.
  • 575
    Nakazawa T, Ohara H, Sano H et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 2005; 30: 205.
  • 576
    Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas 2005; 31: 2831.